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Abstract
Health ca re del ivery i s not s ubject t o the economic fo rces
which achieve p r odu c t i v e and alloca tive efficiencies in
compe titive markets. Al locat i ve e f f iciency is a dd r e s s e d in
t he context of a method s revie.... f or measuring ho sp i t a l bed
ut il i zat i on . Pro duc tive efficiency is addressed by examining
the u tiliza t i on of ciprofloxacin, an expens ive antibiotic .
The r e liab i li ty and validity o f s everal me t hods o f measuring
hos pital bed ut ilization were assessed. Nurse (A)
prospe ctively collected da ta on the clinica l co nd i t ion and
care p lans o f 80 pa tients at an acute care hospital, and
identified and classified i na ppropriate days using her
clinical j ud geme n t . In the same way, a s e cond nurse (B) ,
experienced in appropriateness eva luation, i ndependent ly
rated the sam e cases as did a third nurse (C), using a
modif ied ve rsion o f the App r op ri a t ene s s Evaluation Protocol
(ASP) . Nurse A's dat a was a lso i nde pende nt l y r a t ed by a
pa ne l (P). Agreement for the numbe r of inappropriate
hos pital day s per case as measured using the Intrac laS8
Cor r e l a tion Coefficient (Rr ) was excellent : Nurse A v P '"
0.95, Nurse A v C '" 0 .87, P vs C '" O.BB, 8 v A = 0.B7, 8 v P
'" 0 .79, 8 v C .. 0. 72. Reliable and valid j u dg ement s o f
inapp ropriat eness ca n t hus be made by an y o f these met ho ds.
ii
In t he second study, an academic pan el and an indus try panel
used guideline~' to assess the approp r ia teness of 278
ciprofloxacin prescriptions whic h were generated through
chart r ev i ew and Intervtev of 72 physic ians. Ci p r ofloxacin
was co ns idered to be appropriate l y prescribed i n 42\ of
cases by the ac ademi c panel, and in 62\ by t he indus try
pane l. The only diagnoses where the two panels differed
s ignificant ly were nursing home-ncquLra d pneumonia (p c
0.0005) and acut e exacerbation of chronic bronchitis (A.E:CB)
(p e 0.0001) . Agre ement between the two panels was fa i r (K
" 0 . 36), but agr eement i ncr eased to moderate when ca ses of
nursing home-acqui red pneumonia and AECB wer e r emoved (K "
0 .S8l .
Inapprop r iat e prescript ion of ciprofloxac in inhibits
productive efficiency i n the health car e system end stems
from a combination of lack of knowledge of pharma cother apy
for co rn:non infections , as well as a lack of knowledge or
concern fo r the cost d ifferential among an tibiot i c
a l t ernatives . Physician educat ion through academi c
detailing is needed to disseminate price informa tion and
appropriate gui delines with the inte nt of impro v i ng
physician presc ribing behaviour .
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SECTION I
CURRENT STATE OF THE
CANADIAN HEALTH CARE SYSTEM
1 . 0 BACKGROUND
Canadians have become a c cu stomed to a very high level o f
he a l th care service and be lieve t ha t i t is one of the major
advantages of being a Cana dian resident (Newfoundland ,
Econo mic Recovery commission, 199 4, p .3 ) . Cana di a ns a r e now
fa ced wi t h g r owi n g pressures t o reduce 30vernment
expendi t ures, t he most significant being t he debt crisis in
Canada (Tholl, 199 4). While t he re a re a nu mber o f factors
which co ntribute to the Canad ian debt and budge t deficit
p roblems, the rate of grow th of the cost o f Cana d i an he alth
ca re i s one of t h e most significant. In r ea l 1986 do l lars
spending on he a lth ca re i ncre a s ed from app r ox i ma t ely $1828
per c ap i t a to $20 10 per capi t a f r om 198 7 t o 199 1 (Tholl,
199 4) . Spe nding on heal th ca re i s often a ssessed re lative
to Gross Domes tic Pr oduct (GOP ) since it represents Canada's
ability to pay fo r the services it p r ovi de s (Tholl , 1994 ).
During t he 1990's, Canada has come very close to spend ing
10 \ of i ts Gross Domes tic Produc t (GOP) and employing 10\ o f
its lab our f or ce i n the he a lth services s ector . As r ecently
a s 1980, Cana da spent only 7 . 5\ of i t s GDP on health
(Blomqvist , 1994 ; Evans , 1984 , p .9). In addi tion , he a l th
care spen ding inc reased a lmost 5\ annua lly i n real t erms
du ring t he 1 980 ' s (Blomqvis t , 1994 ) . This growth , While
ha ving the g oal o f enha nc ing human we l fa r e, has a
su bs t an tia l opp o rtunity cos t . This mea ns t hat the l a bour
and other r esou r ces c on sume d to produce health se rvi c es are
no t a va ilable to pr oduce othe r wor thwhi l e goods and s ervices
t ha t migh t be e x po r t able and which cou l d contribute to the
eco nomi c weU·be ing o f the cou ntry (Bl omqvis t , 1994 ) . Thu s ,
the growth ot e xpend i tures t hreatens t h e very weal t h t ha t is
needed t o support t he sys t em Canad i ans v a lue .
I n order to determine why Can ada face s thi s s i t uat ion , it i s
ne ce ssary t o t u r n to t he fie ld of economics, The fo llowing
sec t ion briefly r ev i ews some eco nomi c i s s ues relevant t o the
health c a r e i ndus t ry .
1 . 1 OVERVIEW OF HEALTH ECONOMICS
The unde r lying proble ms in Canadian he a l t h ca re de livery
relate t o t he economi c conc epts of product i ve efficie ncy and
allocative effi ciency (Newf ound l a nd, Economic Recovery
Coomi s s ion, 199 4 , p . 3) . Product i ve! ef ficiency occurs whe n a
particular l evel of heal th care service is prov id ed at
lowest poss i ble cos t . All oca ti ve !!ff ici ency occur s when the
opt ima l l e vel at hea l th ca re service i s provided . I n a
co mpetitive market productive an d a llocative e f fi cie ncy an.'
t heoreti cally achieved because of the un de r l y i ng f o r c e s o f
t he price system . Firms i n a compet i t ive mark et wi ll a ch i e ve
product ive eff iciency because the y have unde r lyi ng profit -
maxim ization mot ives which encou rage t hem t o operate at t he
lowest possible cost . Allocative efficiency is achieved
over the l ong run in the competit i ve ma r ket because t he
market s tructure al l o ws for t he free entry and exi t of
co mmodi t i e s an d firms in the mark etplace . Therefore, the
price paid by consumers fo r a commodity wil l r e fl e c t the
value of the resources used by the f i rm t o produce i t
(Ne wf oun d l and , Economic Recovery Commis s ion, 1 994, p .3).
I n t he h e alt h service sector productive and a l locative
efficiencies are difficult t o achieve . Physicians a cc ount
for a l a r g e prop ort ion of h e alth spending through direct
payments for t h e i r services , as well as the resources they
co nt rol, such as l ab teats , prescription medications,
admission to hospitals, surg i cal procedures , and the use of
va r inus diagnostic t e s t s (Ne wfoun d land , Econ o mic Re co ve ry
Commiss ion, p .9 ; Culyer, 1988 , p.38 1. I n Newfound land,
15 . 1\ of the 1995 bu dget was allocated f or d i r ect p ayments
for physician services through the Medical Care Commission
(Ne wfo und l and , The Bu dget i n g Di v i s i on o f Treasury Board ,
19 9 5 , p .2331. and ap proximately 6%" of t he provincial
government's health budget is spent di rect ly on prescription
medications (Ne wfoun d l and, The BUdget i n g Division o f
Treasury Board, 1995 , p .232 -233 ) . In addition , when one
considers that physicians control approximately 70\ the
dollars spent on i npa t i e n t ca re (Restuccia et ai , 198") , and
that 65% of the Newfoundland hea lth care budget is spent on
hospitals and nurs ing homes (Newf ound l a nd , The Budgeting
Division of Trea sury Boa r d, 1995 , p.224) , one can estimate a
further 45 .5\ o f spending under the control of physicians.
Without considering physician contributions to the cost of
delivering Community Health programs (9 .5\ of t he bUdget),
o ne can obtain a rough estimate the value of health
r e sour c e s cont rol led by physicians at about 66\ of the
budget, or app roximately $580 million. Since physicians are
g uaranteed a fixed fee for their services regardless of t he
number of providers, and since the cost of over-utilizat i on
of resources is not bo rn by these physicians , there exists
l i t tle incent ive to produce at the l owe s t posslble cost.
Productive efficiency i s therefore not ach ieved. An examp le
of productive inefficiency wou l d be the over-uti lization of
expensive drugs , such as ciprofloxacin , a f ocus of this
thesis . since the incremental cost of a c iprofloxacin
presc ription over a cheaper alternative does not i mpa c t
d i rect ly on either t he consumer (when covered by a
gover nment J rug plan or other insurer) or the physician, it
i s prescribed more often than i t sho uld and productive
efficiency is compromised.
s ince pat ients do no t d i r ec tly pay t h e marke t v alue for the
services they rece ive, and since phy s i ci ans feel no persona l
pressure t o a lloc ate res our ce s in t he most. cos t-effect ive
manne r, there tends to be an excess amount of service
demanded an d provided , r esul t i ng i n a llocat ive
ineff iciencies as well (Newfoun dland, Economic Recovery
Commission, 1994, pA l . Blomqvist (1994 ) contends tha t
there is an i mpli c i t tendency toward a llocating too ma ny
re sou rces to hea lth, e ven in ccmpet.Lt.Lve h e a lth care
markets . Further, in t h e hea lth services industry the gap i n
knowledge between p rov i d e r an d consumer is unparalle l e d in
any other ma rket. This i mpairs allocat ive ef f i c iency,
consumers do not know t he t rue value of t h e commodity
(B1omqv i s t , 1994 ; Evans, 1984, p.123) . An e xample of
allocative ineffi ciency i s i n a ppropr i ate ut iliza t i on o f
hosp i t a l be ds. I n 1990-91, Ne wfoundland ' s hospital
occ up a ncy r a te wa s only 70 .59% , lagging be h i nd the Ca nadian
averag e of 79 . 9\: d uring that p eriod . The l ower oc cupancy
rate p r ovide s more ro om f or dis cretio nary a nd p recautiona ry
use o f services (Ne wfo undland, Econo mic Recover y Commi ssion,
1994, p .6). Repo r t in g on a bed uti l i zation stud y at t he
Gene ra l Hosp ital in St. Joh n' 5 , Bar rett e t a l (1994) f ou nd
that a lmost one t hird of hospi tal days were pot e n tial l y
avo i dable t h rou gh su ch measur e s as im pr oved discha rge
p l anning, utilization o f a Pr e admis s ion Cl i n ic (PAC), a nd
more ef fi cient medica l man a gement . Anothe r e xample of
allocativ e inef ficiency an d subsequent i nc rease in c oat; t o
bealth c a r e iJ t he de v elopmen t a nd usc of ne w tech nologies
(Ev an s, 1 984, p . 95 ; Newfo undland , Economic Recovery
Commi ss i o n , 199 4 , p.12 ) . Unl ike ene marke t economy, new
t e c bllolog i es a re not i ntroduced t o lowe r cost, but instead
to i mprove quality of care , and ccse e of t en actual ly
i n c r eas e due t o i ncreased skilled labour r equirements
(Newfou ndland , Economi c Recovery Corranission , 1 994, p.12 ) .
Howev er, the ne t impact of techno logica l change i~ rea lly
un k nown since t h e i t is unknown whe t her tbe expend i ture-
increas ing effects of high t echnology ou t wei g h the
expenditure -d e creasin g e f f e cts (CUlyer, 1988 ) .
1 • 2 CONTl!.OLL:ING HEALTH CARE EXPENDI TURES
I n Canada , the pub l ic sector is largely r esp o ns ib l e for
carrying out h e a lth care functions, wi t h pub l ic s pending
accounting for 72 -73% of all health care spending (Tholl,
1994, p . 61; Newfoundland, Economic Recovery C')mmission,
1 9 94, p .4) . The admi nist ration o f these health services i s
under provincial jurisdiction as provided by t he Canadian
constitution, but the provinces must op e rate with i n the
nationa l principles of universality, c omprehensivenes s,
accessib i lity, p or tabili t y and non-profit administration if
they are to receive the federa l financial transfers critical
to the ability t o offer t hese p r ogr ams (CUlyer, 1988, p. 47 ;
Ne wfoun d l and , Economic Recovery Commiss ion, 1 9 94, p . 2) . The
Newfoundland government spends a p pr oxima t ely 23 .3% of it s
budget on health care (Newf ound l a nd, The Budgeting Divis ion
of Treasury Board, 1 9 95, p. vi i i), which is l e ss t han the
Canadian average (approximately 31.6\ in 1991) . However,
Newfoundland's posi tion of being heavily dependent on
federa l financial r esources means that i t faces extreme
pressure to ra tiona l i ze its spending when fe deral transfers
are f rozen or reduced. In its 1 9 95 bUdget, the Canadian
government indic '.ted it wo uld be reducing co mbined transfer
payments for a ll provinces by $7 billion over t hr e e yea r s
(Naylor et a L, 1995). Since the provinc e is i n effect a
single paymaster a n d is n ot faced with a multitude of
financial int ermedia rie s (as i n the United States), it
reta ins the abili ty t o exercise discretion o ver it s
spending . Th i s does not ensure expenditure constraint, but
at l e a s t provides the opportun ity to do so (Cu1yer , 1988 ,
p ,48) . So while the Can a dian system introduces s ome u nique
chal lenges to control costs and effectively allocate
resou rces a mong co nsum ers of h e al t h care , p r ovi n c e s have the
abili t y to control those expenditures . Accomp lishing t his
requires ca reful study o f where t he inefficiencies are
occurr ing i f one hopes to design pr oper et. r-a t.eqa e s to c ea i
with wasted resources. Once ident i f ied , strategies must be
deve loped to cur t a i l the prob l e m. A number of s uch
i nt e rvent i o n s t ra t e gi es i ncluding phys ic i a n educ a t i on ,
feedback, a nd academic de tail ing are di scus sed in Sect ions
II a n d III.
1 .3 SUMMARY
Given the e c onomic and f iscal p r es su r e s t o reduce healt h
care co s t s a nd t he assumpt io n of product ive and allocative
inef ficiencies i n the Canadian healt h care system, it in
essential t hat cc s e -er rect .ive and accurate tools f or
nleasuring utilizat i on o f health ca re resources a re
deve loped . Studies must be carried out whic h identity and
qua nt i fy t he prob l e m area s , a nd suggest st rategies and
tactics t o r educe inappropriate uti l i zat ion of health care
Section II addresses the evaluation of al l o c at i v e eff iciency
i n the hos pital s e ctor by assessing the rel iabi li ty and
validity of severa l met hods o f measuring b e d ut ilizat ion in
acute care hospitals . Section III a d dres s e s P' . .ccci .ve
efficiency through a drug ut i l izat ion review of an expensive
antibiotic , ciprof loxacin . Bo th se ctions discuss some
i ntervent ion strategies which might be employed to reduc e
over - utilization of t he s e hea l th care resources, th us
improving al l ocat .i.'ve and productive efficiency in the
syste m.
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SECTION II
METHODS OF MEASURING BED UTILI ZATION
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2 .0 INTRODUCTION
Bed utiliza t ion review can be u s ed by hospitals t o measu re
and un derstand reasons fo r i na p p ropria t e utilizat ion o f
hospital beds (Restuccia et a l , 1987). Administrators
then identify areas of potential cost reduction while
maintaining the ability to meet patient needs. The
me t hod (a) used to carry out bed utilization re view muat De
valid and cost as l i t t l e as poss ible i n order t o max imi z e
t he re turn on t he research inves tment . Traditionally. most
me t hod o l ogi ca l studies on appropriateness have not been ab le
to produce reliable measu rements (Rishpon et aI,
~ 9 86 ; Gertman and Restucc i a, 198 1 ). A major barrie r to
development of a tool to measure appropriateness of hospital
stay is that there is no gold standa rd agains t which to
compare results .
T he Appropriateness Evaluat i on P r ot oc o l (AEP) ia an
o b j ect i v e , cz-Ltez-i.a-baaed instrument used to identify the
extent of , and re asons for inappropriate adm issions and
h o spi t al days (Restucc ia et at , 19B7). It has been shown to
be re l i abl e and valid , and has been used effective ly in a
n u mber of hospital settings i n North Americ a and abroad
(Payne et aL, 1991;Strumwasser et aL, 1990;Siu et a l ,
1986;Reatuccia e t a L, 1987 ;Rishpon et a L, 198 6;Gert.man and
Re s t uc cia , 19 81) . Demons tration of reliability and validi ty
h a s been ach ieved by comparing t he assessments of several
1 2
nur s es and phys icians who independe nt l y assessed pat i ent
hos p ita l s tay using the AEP, and t hen cal cul ating t he
agreement be tween observers generally , and co rrecting fo r
cha n c e us i ng t he kappa s t ati stic (Strumwasser ee ar ,
1990jSiu ee ak, 1986;Rishpon et a L, 1986jRestuccia e t; af ,
198 6jRestu ccia e t aI, 19B2;Gertman and Restuccia, 1981) .
Thu s , in t he ab s ence of a g o ld sta nda rd, the AEP ca n be
consider e d an e xcel lent too l upon which t o co mpare other
measurement tools being deve loped.
Barr ett e t; al h a ve previous Ly reported studies of bed
uti l izat ion at t he General Ho spi t a l in St. John ' s, NF
(Ba rret t e t ai , 1994 ; Barrett et e.L, su bmi tted) . I n t hes e
studies , app ropriateness of h osp i t a l stay was assessed by a
mUlti-disciplinary panel of socia l workers , nurses and
phy s icians. The panel rev iew process was bur densome , cost l y
and l ed to delays in obtain ing results. In addition , t he
su b jective decision making employed by t he panel allowed t.he
poss ibil i ty of biased decisions.
Thi s section o f the t hes is tests t he rel iabi l i ty an d
va l i d ity of met hods used to i dent ify and classify
i napp r opr i at e hospita l stay in a subsequent b ed ut i l izat i o n
review. The s pecific objec tives o f t his s t udy were to : 1)
examine t he fe as i bi lity an d reliabi li ty of having a t rained
nurs e prospect ively abstrac t in format ion r el e v ant to
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determining appropriateness of bed utilization from medical
records and charge nur ses I and (2 ) val idate the data
collection and decis ion mak ing of the individual nurses as
we l l as the decisions of a r evi e w pane l aga i nst a modified
version of the AEP .
2 .1 METHODS
2.1 .1 Patients and Recru itment
For the overall bed u t i li z a t i on study, 203 patients admitted
to the Genera l Surgery, Urology , Pl<lstic Sur g e ry/Bu r n s ,
Ophthalmology, Haematology, Radiotherapy ,
Gynaeco logy/Oncology . and Infectious Di s ease services at the
uene ra i. Hospital were studied . In order t o get a
represen tative sample from each service , admissions to
General Surge r y and u rology were studied for 2.5 weeks, and
those to othe r services for 5 weeks . The sample s ize was
one of convenience, taking budget and time constraints i.n t.o
account.
A n u r se (Nurse A) wi th considerable clinical experience, but
wi t h limit ed t r ai ni n g i n utilization review ident ified and
fo llowed all 203 study patients on a daily basis. To test
the r eliab ili t y of t he data gathering process. 80 p a t ients
were se lected (by coin toss) and f ollowed prospect ively b y a
second n urse (Nurs e B), using the same met hods as Nurse A
14
(Nurse B trained Nurse A for this study). I n th e same wa y ,
these 60 cases were fur t h e r studied by a thi rd nurse (Nurse
C ), us i ng the AEP. Fi na l ly, a pane l of nurses and
physicians ret rospectiv ely eval u a te d the same 80 patient s
using the data col l e ct ed by Nurse A. The 8 0 cases were
sel ected to be represen tative of t he po pula t i on from which
t hey we re drawn in the same way a s the 203 patients fo r the
overal l study (se e table 2 .2 i n Resu lts sect ion ) . All
recruited patients were followed to di s cha r g e wi t h the
exception of t hose transferred t o a non-st .ud y service . Su ch
p a t i ent s we r e fol lowed up to the time of t r a nsfer .
Nu r se s A and B us e d a standard ized form (Ap pendi x A) to
record clinical and demographic da ta , a daily pro file of th e
patients ' me d i cal c ondition , medical and nu r s i ng
interventions , and the plan of care from hospi tal ad mi ssion
to di s c h ar ge . Un i t cha r g e nur s e s were regu l arly consul t e d
about t he patients ' cond i t i on and plan of care .
2 .1 .2 :Identifi cation and Clas s ification of :Inappropriate
Hospital Day s
Nurses A and B i nd e penden t l y i d e n t i f i ed and classified
i n appropriate hospital days using a structured f o rm which
cla ssi f i ed r e asons for t h e s e days (s e e Appendix B) . This
c lassi fi cat ion sys tem was gene rated us ing t he AEP an d the
"Del ay Tool" (Sel k e r et aI , 1989 ) . T he Delay Tool was
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de veloped to detec t, quantify and assign caus e s for
unnecessary hosp i ta l s tay in tertiary teaching hospitals.
using this same c lassification system, a pane l of 3
phys i c i ans an d 3 charge nu r s e s from the study servi ces also
identif ied and c lassif ied i nappropriate days from data
presented by nu r s e A. In making their decisions , t he panel
f ol l owed some pre-ag r e ed gu idelines. These s tated t hat : a
pre-admission clin i c should be us ed for s table elective
s urgical cases n ot need ing extensive pre -operat ive wor k-Up;
consults, t ests and ope r a tions should be done within 24
hou r s o f reques t; patients should be discharged as soon as
t he ir medica l a nd social circumstances permit; early
discharge planning should be underta ke n f or i de nt i fi a b l y
difficult cases ; and that a thorough admission assessment
should i de ntify all e x i st ing problems and result i n a
coordinated medica l care p l an . The pane l was blind to
patient i de nti t y , and t o the de cis i ons o f t he o ther r aters .
Nurse C used a mod ified version o f the AEP t o perform t he
s ame t ask an d wa s blind to the data col l e c t i on and decis ions
of Nurses A and B. The AEP was developed in the United
St ates , but was modified t o r efle c t loca l market differences
in heal t h de livery . The AEP was modified to r e qu ire t h e use
o f a preadmission c l inic where suitable, and by eliminating
a c riterion that a llowed f or a post-ope r at ive da y f or
several i nva s i ve d iag nos ti c procedures , such a s angiog r aphy
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and myelography . .rm additional modif icat i on was t o require
ho me ca r e when only intramuscular an d/ or su bcutaneo us
inj ec tions or d r€!ss i ng changes were ne eded. These
modificat ions did not change the wa y i n whi ch t he AEP was
administ e r e d , s o su bsequent val idat ion of t he modified tool
was not deemed a s necessary .
2 . 1.3 Ethics
This s tudy was approv ed by t he Human Inve s tig a t i on s
Commit tee a t Memorial Universi ty o f Newfoundland . No pa tie n t
co ns ent was r equ i r ed as there was no intervention whi ch
might impact on pa tient s t ay or he alth outcome. Patient
i n f ormat ion wa s obtained t hrough c h a r t abs t ract i on wit hout
any patient c ont a c t . Con f identia lity was mai n tained by no t
us ing pat i en t i dentifiers on any s t udy d ocument s or repor t s
to be seen by a nyo ne other t ha n those provid ing care or who
were directly i nv olved i n the s t ud y .
2.2 ANALYSIS
The deg ree o f agreement between nurses A and B i s a tes t nt
inter-rater reliabili ty of t he no n -ur-Lt.e r-La-dr Iven met hod .
The degree of agreement between A and t he pa ne l wa s studied
to see whe ther panel r eview could be avoided in f utu re
studies . St r ong agreement be tween A and C provides a
validity che ck on the data collection and j Udge ment a bil i t y
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of Nurse A. Strong eqreement; between any of A, 8 or the
Panel with the AEP provides some v a l i da t i on o f the part ially
subjective j udgement methods . Decis ions about
appropriateness cannot be tested for cri terion validity
be caus e there i s no go ld standard "criterion" method for
j Udgi ng appropriateness.
Inter-rater agr e emen t was assessed for : 1) appropriateness
of admission; (2 ) reasons for inappropriate admission day;
(3) total numbe r of days i nappropriate; and (4) number of
inappropria te d ays due t o a specific reason . The k appa
sta t istic (K) was used t o assess agreement for nominal data
su ch as appropriateness o f the admission day and reason fo r
i n app r opr i a t e admission day (Krame r and Feinstein , 1981;
May, 1994). Intraclass correla t ion co e f fi cients (R1 ) were
used to a ssess agreement for c on t i nuous data , including the
t o t a l number of i nappropriate days and the numbe r of
inappropriate days due to a specific reason (Kr amer and
s e t n a t e f n , 1981; May, 1994 ). Landis and Koch 's (1977)
guidelines f or interpretation of kappa were used to evaluate
strength of agreement between raters . The se gu idelines
(tabl e 2 .1) are also applicable for evaluat ing R1 (Kramer
and Fe instei n, 1981). The at r e ng t h of agreement necessary
to validate t he met hod of c oncu r-re nt; da ta cc f re ce dco and
decision making by nurse A was c onsidered to be substantial
or better using these gu idelines .
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Table 2 . 1 Gu i deline s f or I n terp r e t i ng Kappa IK) an d
I ntra c l a s s Correlation Coe f f icient IR1 )
Value of II: or R1 Streng tb of Agreement
< 0 poor
0 .00 0 .20 s ligh t
0.21 0 . 40 f a i r
0.41 0 . 6 0 moderate
0.6 1 0 .80 su bstant ia l
0.81 1 .00 almost pe rfect
Baseline characte r i st i cs were evaluated using stude n ts e -
test and chi - s qu a r e test wi th Ya t e s co r rection where
applicable .
"
2 . 3 RESULTS
As s hown in t ab le 2.2 , there we r e no s i g ni f i c an t di f ferences
a t ba se l ine between the 20 3 patients i n the overall be d
utilization review a nd t he pa tient s i n t his sub-study .
Table 2 . 2 : pat i ent Baseline Characteristics in the
Ut i li z a t i o n Study and the Met hods Sub -s tudy
Ut i lization Agreemen t
S tudy (N.203) Study (N .. aO )
Mean Age (y r s) 52 57 (p",O . 13 )
Male ,t) 59 55 (p",O .62 )
Are a of Res i dence H 1 H 1
St. John's 1.7 53 4. 5.
Eastern Avalon 6' 32 27 34
Centra l NFLC l ' 7 5 (p",O. 9 4")
West /St . Anthony 1. 5 5
No r t he r n NFLD & Lab . 4 2 ,
Outside Province 4 2 2.5
• St . John '" an d Eaote rn Av.. l . Pt o f ro m Remainder o f Prov in ce
~
Elective 59
"
26 33
Urgent 55 27 2S 31 (p-O. 3 0)
Emer genc y 8 9 4' as 36
Admitt ing Servi ce
Surgery 59 29 24 3.
urology 52 2 6 24 3.
Plastics /Burns 19 9 4 5
Haema t / l n f e c t . Disease 2. 1. 9 II (p -O . B9l
Radiotherapy 2. 1. 7 9
Gy ne c o l ogy / Onc o l ogy 14 7 4 5
Ophthalmology 19 9 8 1.
2 .
Table 2 . 3 de s cri be s t h e pattern of ag re ement between r ate r s
f or appropri a t en e s s ot: admiss ion d ay and t h e reas on c ited
when i na ppropria t e . As ref l ected by almost perfect
ag r eement between nurses A and B, i n te r - r a t e r reliabil ity of
t he nu rsing data collection an d j Udge menc was very high .
Table 2 .3 : Agre ement on Appr opriateness of Admission Day
Agre ement Us i ng lCappa (9 5 ,\ en
Pairwi s e Appropriate nes s of Reasons f or
Comparison s Admission Day I n appr opriate Admis s i o n
(N_ SO)
A v s P 0.69 0 . 9 0 [N..26]
(0 . 4 7, 0.91 ) (0 .59, 1. 2 1 )
A VB C 0 . 68 0 .33 (N..33 ]
(0. 4 7 , 0 .89) (0 .08 , 0 .58)
A vs B 0 .92 0 .79 [N=3 4 )
(0 .70 , 1 .14) (0 . 5 2 , 1. 0 6 )
P VB C 0 . 49 0 . 30 (N..27 )
(0 . 2 9 , 0 .69 ) (0 . 0 1 , 0 .591
B vs P 0 . 7 5 0 .72 [N..2 61
( 0 . 5 3 , 0 .97 ) (0 .39 , 1. 05 )
B VB C 0.62 0 .41 (N.. 36)
(0 .4 0 , 0 .8 41 (0 . 14 , 0.68)
• NUlllbers i n . qu Ar e b r.eke t ••re ."lIIple . 1&..,. for ",na I y" !"
The validity of nurse A's as vessmene is suppo r t ed by t he
subs t a nt i a l agreem en t be tween A a nd bot h t he pa nel and nurll f:!
C using t he AEP. The r e was a les ser deg ree o f agreement
21
between t he panel and nurse C using the AEP f o r the
appropriateness of admission day. Eighty-six percent of
the disagreements involved the panel declaring the admission
day appropriate while the AEP dec l a r ed it inappropriate .
This resu lted from the panel being influenced by patient
status and the distance travelled to reach the hospital,
leading them to declare a greater number of precperaeIve
admission days appropriate.
The values of K i n table 2.3 for Reason for Inappropriate
Admission Day only include cases where the two raters agreed
on the inappropriateness of the admission, removing the
effect of that disagreement. Again, agreement was high for
reason for inappropriate admission . One may argue that the
agreement may have been upward ly biased by the fact that
comparisons were only made where there was already agreement
on appropriateness of admission day. However, this was
necessary to get a clear picture on the reliabili ty of
classification. A lower degree of agreement was found
between nurse C and a ll other raters for reason for
inappropriate admission day. This was mainly due to the AEP
indicating a premature admission when most others fel t t ha t
the scheduled procedure could have been performed in an
ambulatory set ting .
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There was substantial disagreement between the panel and
other a ll other raters regard ing one case (case IP) . In
this instance, following a lengthy debate, the panel decided
that all 27 days of hospital c are were appropriate. The
panel were aware of the u ltimate l y fatal outcome of the
patient , whi le the nurses rating t he stay in a prospective
ma nne r , did no t know the outcome until day 27 . Nurses A, 8
a nd C a l l rated all 27 days inapp ropriate em the basis that
t he ca re could potentially have been provided in a non- acute
setting. Since t his single case of long duration had a
major i mpa ct on the ag reement analysis, the data was
analyzed again excluding case #7 . Table 2 .4 provides
intraclass correlation coefficients (Rt ) the number of days
i nappropriate an d the percent of stay inappropriate for each
pa ir of rate rs overall, and ex cluding case #7 . Excellent
ag reement exists between all rater pairs when case #7 is
exc l uded an d persists for all comparisons not i nvolving the
panel when case #7 i s inc l ude d . This again indicates the
r e l i abi l i t y of the data e xtract ion process and judgement of
nu rses A and B. In a dd ition . as a tes t of convergent
construct. validi ty, the data also support the va lidity of
each of these methods to i de ntify the degree of
inappropriate bed util iza t i on .
23
Table 2. 4: Agreement between pairs of raters by intraclass
correlation coefficient (RI ) for Number of Inappropriate
Hospital Days including and excluding case #7.
Pairwise R1 excluding ca se #7 R1 inclu ding case #7
Compari s on ( .95% CZ) (9 5% CZ)
A VS P 0 .95 0 .40
(0.92, 0 . .97 ) (0.20 , 0.57 )
A VS C 0. 87 0 .94
(0. 8, 0 .91 ) ( 0 . 91, 0 .96)
A VS B 0.88 0.36
(0 .82, 0. 92 ) (0 .15 , 0.54)
P VS C 0 .87 0 .98
( 0 . 8 , 0 .91) (0 . 97, 0.99 )
8 VS P 0 .79 0 .30
(0 .69 , 0.86) (0.09, 0 .49)
8 VS C 0 .72 0 .86
(0.59 , 0.81 ) (0.79, 0 .91)
The strong agreement between nurse A and the panel ( t a b l e
2.3 and table 2.4) means that panel review for the remaining
1 23 patients reviewed by Nurse A could be avoided . Table
2 .5 describes the pattern of inappropriate bed ut ilization
for all 203 pa t ients as determined by nurse A .
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Table 2. 5: Descript i on of Hospital Stay f or all 203 patients
reviewed by Nurse A.
Pa t i ents Days \; of Total
Hospital
Days
Total Hospi ta l Days 203 1261
Median Length of Stay s
Tota l Inappropriate Days 10' 317 2 '
potentially Avo i dable days 5 64 5
wi t h New Services '
potentially Avoidable Days
within existing services :
Awaiting Surgery 4S 59 5
Awaiting Dia gnostics 2 1 3B 3
Awaiting Consults 0 0 0
Await ing Results 1 1 0 . 1
Medical Management 19 77 6
Di s c har ge Delays 4 0 78 6
New serv ices I nc:lude s upe rv i sed hoste l- typs f ac il i t ieB, communit y
Bupport s ervic es in liaison with acute c ars and sall ie r aecee .. t o
co nvaleecent and p a ll iat i ve ca r e u nits.
Raters A, B and the pa ne l co uld be mean ingfUlly co mpa red
with regard to the proportion of i nappr opr i a t e bed days d ue
to a !:Jiven reason (tab l e 2 . 6 ) . The a nalysis includes c ase
number 7 a s al l r aters agreed t hat he /she di d not ha ve an y
i nappropriate d ays due to the se reasons . The re wa s
substantial agreement between raters with r ega rd to the
major reasons for i nappropriate bed days fu r t he r s upports
the reliability and validity of t he pa r tia lly SUbjective
processes employed.
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Table 2 . 61 Compa r ison o f R! (95\ eI) value s fo r Raters A,
B, and P for Reasons for Inappropriate St ay .
A vs P A vs B B vs P
Awaiti ng 0 . 91 0 .8 7 0 .8 3
Diagnostics (0. 8 6 , 0 .94 ) ( 0 . 80, 0 .91) (0 .75, 0 . 89)
Awaiting 0. 59 0 .4 7 0 .35
s u r gery (0 . 4 2 , 0. 72) (0 . 2 8 , 0 . 6 2 ) (0. 14, 0. 53)
Awaiting 0 . 86 0 . 77 0.79
Discharge (0. 7 9, 0. 9 1 ) (0 . 6 6 , 0 . 8 5 ) (0. 69 , 0 . 86)
Inefficient 0 . 94 0 .9 7 0.92
Medical (0.91, 0 . 96 ) (0 .9S, 0 .98) (0 . 8 8 , 0 . 95)
Management
Inap pr opria t e days were c lass ified diffe re ntly by the AEP
except f or days awai ting sur ge ry and d i agnost i c tests .
Nev e rthe less , there was ve ry little a greemen t bey ond ch ance
between t he AEP and al l other raters ab out t he number o f
d ays awaiting d i agnostic t ests (R1 0.06 to 0 .07) . All
r a t e r s othe r than the AEP fe lt that case 1# 29 had 7 t o 8
inappropriate day s await ing a diagnos t ic t e s t that cou l d
ha ve been pe rformed on an ou t pa t ient ba s i s , while t he AEP
did not de tect any such inappropriate day for t his case. If
this ca s e i s i gnored . t h e i n t r aclas s co r r e l a t ion coef f icient
rises t o ab out 0 .2 5, r e f l ect ing modest agreement . Si mi l a r
l e ve l s of "':fr e ement were observed between each r a t e r a nd the
AEP f o r t he number of d ays a wa i t ing s u r gery .
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2 . 4 DI SCOSSI ON
2 . 4 . 1 Reliability and Validity of Methods AlI8essed
This s tudy su pports t he r eliabili ty and validi t y o f having a
nuree col l ect data to jUdge the app r opriatene s s o f bed
u t il i zation using pa r tially implicit criteria . The use of
s t a nda rdized da t a co llection f C!rm5 a nd an inappro pria teness
classificati on s ys t em may hav e i ncre a s ed the r e lia b i li ty of
the process .
Nurse A ha d not been previously involved in a hospita l bed
utilization review, but was clinically experience d and had
he ld a nursing supe rv isor po s i t i on in critica'. care . The
s t r o ng agreement between Nurse A a nd Nur s e 8 suggests that
u t i liza t ion rev i e w can be s ucces s fu lly pe rformed by a nu r se
in t his way af ter limi ted t r aining . Howeve r . nurse 8
trai ned nurse A an d bo t h intervi ewed the same ch a r ge nu rses
about t he s ame cases f or t h i s study . It woul d have been
preferable to compare t wo c ompletely i ndepe nden t nurses t o
gauge the reliab i lit y , ho weve r that would ha ve r equ i red
Nur s e B to train another nurse , increasing t he c os t o f the
s t u d y be yond the re sources available . Si nce t he method
employ ed may have con t r i but ed to the ext r eme l y high level of
ag reement between these t wo rate rs, a fur ther study wi t h new
nu rses wou ld be ne cessary t o confirm the reliability of this
me t h od.
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The substantial to exce l lent a gr eeme n t between nurse A or B
and the panel wi th regard t o appropriateness ot' admission
day and reasons for inappropr i a t e admission suggests by this
tes t of convergent construct validity that bo th nurses and
t he pane l are ca pable of judging app ropriateness of
admission. The r e was also substantial to excellent
ag reement be t wee n nu rse A or b and the pane l for the number
of inappropriate days and the reason for inappropriate
hosp ital s tay, whe n excluding a single exceptional case.
The d i sagreement t ha t resulted from this l ong s tay may have
be en due to the d iffe rence i n perspe c t ive of t he pane l
versus the n urses . Tha t is, be caus e the nurses evaluated
the c a se p rospectively , they likely had a better account of
the c linical uncertainty sllrrounding the case, and t heir
decisions t h e r e f ore might be considered to probably be more
va lid . The panel considered the entire stay (27 days)
appropriate afte r much debat e, giving "be ne fi t of t he
do ubt. " Ove ral l r e sult s s uggest tha t there may not be a
n eed to use the costly and cumbe rsome panel r ev i e w process
empl oyed in prior stud ies as l ong as t he d i s agr eemen t i s
conside re d acceptable (Ba r ret t ee a L, 1994; Bar rett et e a ,
submi tted) .
The pa rt i ally subjective method of judging appropriateness
of stay deve loped by Barrett et a l a r e va l idated b y the
s trong observed ag reement be t ween nurse C us ing t he ASP a nd
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the other raters. It is instructive to examine the
instances where there was a lesser degree of agreement
between the AEP and the other raters. Disagreements on the
appropriateness of admission days were mainly due to nurse
A, nurse B and the panel taking greater account of the
patient status and distance from the hospital. Whether
slightly sicker patients travelling longer distances should
be admitted the day prior to an elective procedure is an
aspect of institutional policy that is likely to differ from
place to place and over time . In this regard , the implicit
judgement system developed by Barrett et al may offer the
advantage of being more responsive to such local factors,
but in being ec will not allow unambiguous comparison
between hospitals.
As explained in the results section, the version of the AEP
employed was l e s s sensitive to the possibility of having
procedures performed in an ambulatory aet t rnq . r t does not
specifically guide the user in judging whether a given
patient requiring a procedure should be managed in an
ambulatory setting. Nurse C had the option of overriding
the AEP criteria in this regard, but did not do so, possibly
due to an absence of cuing by the instrument.
Although there was very good agreement be tween the nurses
and the AEP for the number of inappropriate days, there was
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much lower agreement when c l ass i f ying inappropriat e days .
This may be due to diffe rences in t he classificat ion options
avai lable to the j udges . It would be interest ing to study
t he pattern of a greement between the pa r tially implicit
rating system employed by the nurses and t he criteria-based
AEP while ha ving classif i cation of the reason f or
inappropriate days done in a conunon fashion.
2 . 4 .2 Deciding Which Method to Employ
While t hi s study f ocused on ha ving a nu rse carry out
concu r r e nt utili zation review, exactly who should ca r ry out
t hes e util ization reviews cou ld be a point of debate .
Li nt on and Peachey (19 89 ) a rg u e that physicians should
de velop systems o f u t ilization r eview, and should su pe rvise
data collection and analysis. I nde e d , phy s i cians as
r ev iewers migh t be more kno wl e dgab l e abo ut t he complex i t i e s
of the medical care required , while al s o h aving knowledge o f
hospital systems and processes . In add i t i on , de tailed
patient review mi gh t res u l t i n en ha nced care , and be i ng
involved i n the review migh t faci litate change. This would
be espe cia lly true if the attend ing physician wer e carry i ng
out t he review. However, phy s i c ian uti l iza t ion re view ha s
disadvant ag es . If physicians were judging their own cas e s ,
a s ignificant bias would exist, a nd one might thus qu estion
t-tie v a lid i t y of the assessments . The process is also t ime -
consuming and might t he r e f or e det ract f rom patient care .
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physician t i me is a l s o qu i t e expensive in compa r i s on t o
nursing or cle rica l t ime . Us i ng nurses o r non-clin i cal
s ta f f provi de s a cost adv an t ag e . great e r obj ectivi ty. and
prob able equiva lency regar d i ng know ledge of hospita l systems
a nd pro cess es . The r e sult s of t his study sug g es t t h a t
t r ained nurse s ca n carry out bed u t il i z a t i on r eview e ither
u s i ng gu i de lines and clini c a l j Udge ment . or by us i n g a
cri terion-ba s ed appr oach , s u ch a s t he AEP. One advantage of
t he cri teri on -ba sed a pproa c h is the pos sibil ity of h av i ng
i nit i al r e views carried out by noro- clinic al sta f f, t hereby
furthe r r educ i n g t he cos t o f t he p r oc e s s . However, r i gid
c r i teria may b e teo i nfl ex i ble f o r the complex i tie s of
indivi du a l patient care an d may not cons i der l ocal mark et
differen c e s i n he alt h care delivery as would a panel or
nu rse using guideline s . Fu r thermore , a criteri on·based
met hod such as t he AEP does not question t he r.eed f o r a
p r ocedure. bu t ins tead j udg e s appr opriateness of sta y gi v e n
that the procedu re i eself i s warranted.
Bo th me t hods o f bed utilization r e vi e w t es t ed here a ppear
reliablp- and valid . a nd the cho i ce of o ne ove r the o ther
wi l l depend on re sources ava ilable , t he she o f the
i nstitut i on , a nd the speed at wh i c h the r evi e w must be done.
Ong oi ng bed u t il iza t i on would be f acilitated by pr i mary
co mputeri zed input o f da t a , a llowi ng cl i n i cal teams an d
administrat ors to a n a l yze the data on a n ongoing ba s is
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(Payne et a t , 1991). Whichever approach i s used, the system
shoul d have a f eedba c k mechanism so tha t cl i n ical t e ams may
comment on t h e r esults , an d de ve lop plans of action to
correct an y systema t ic problems i d ent i f i ed .
2 . 4 . 3 Limitations of Study
The re are some points of possible criticism i n this study .
Nurse A was once a s up ervi s or in c r itical ca re, an d one
might argue t hat freeing the time of such a r e source might
pro ve difficu l t . I t mi ght a lso be argued tha t a staff nu rse
mi ght no t pr ovide t he same l evel o f assessmen t as s omeone
with su pervisory nurse exp erience. Furthermo re, wh ile Nurse
A did not have previous ex perience '::a r ryi ng out a bed
utilization r eview, s he was in co ntact with nurses who we re
i n v olved in the origi nal study by wor king wi t hin the s ame
group of people , thus th e re may be some co nta minat ion i n
that she co u l d pos s i b l y ha v e l earned about t h e ASP through
casual c on ve rsation , or by overhear ing conversat i ons
r e l a t i ng t o t he t op i c . Fi nally , t his s tudy was ca r r ied ou t
i n a teach ing h osp ital wi t h a f oc u s on research, an d in
whi ch a similar stud y was conducted in the p revious year .
Therefore , the r eaction of physicians a n d charge nu r se s may
ha v e be en inf l uence d by these t wo factors, although the
imp act on rel i a bil i ty is unclea r . Fur t her s t udy could
de fine t h e importance of t hese co ncerns . Such a s t udy
s hould be carri ed out us i ng a no n -teach ing acute care or
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sub - a cute facilit.y usin g a staff nu rse wi t h a s ignificant
amount of c linica l expe r i ence t o eeec ene generalizabil i t y
of these r e s u l t s .
2. 4 . 4 :Intervention Strategies
While this s tudy did not focus on t he actua l ut i liza t i on o f
hosp ital services . studies by aareeee et a 1 (19 9 4 ;
submi t ted) ha ve de monsc rated t hat between 2 5 and 33\ of
hospital bed da ys in t he Gen e ral Ho s p ita l were avoida ble .
This is s imi lar to othe r studies which have found th a t
bet ween 20 -3 0\ of tota l pat i ent days are inappropriate
(Wickizer e t at , 1 989 ; s f .u et aI, 1986) . Gi ven the
inefficient use of hospi tal resour ces , it is use ful t o
examine s ome i ntervention strat egies to reduce u nnece s s a ry
hospi t.al admissions and length of stay . Such i n t e rv en t ions
include education, fi nancial i ncent i v e s and penal ties,
f eedback , a nd admi nistrat i ve c hanges .
Cont inuing Medica l Education (OIBI r e f e r s to the education
of practising phy sicians . CME can alter physician behavi our
when t h e curriculum i s designed to c hange s pec i fi c types o f
behaviours (Greco and Eisenbe rg, 1993 ) . Th us, among i tems
to be i nclUded in CME tor bed ut il i zation would be use of
the p readmission clinic for e lect ive su rgeries and
information on e f fec t ive ea rly discharge plann ing .
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Feedback i n v olve s giving phy sicians i nformation about how
thei r pr a c t i ces or patient outcomes compa re wi th other
phys icians or wi th some standard (Gr e co and Eisenberg,
1993 ) , such as t he AEP or any method of bed ut i lizat ion
revie w. Whi le feedback has not ge n e r al l y been effective at
changing physician behaviours (Greco and Eisenb~rg , 1 9 93) .
it has been shown to be ur.efu L i n reducing hospital stay
(Gr e c o and Ei senberg, 1993 ; Billi JE at a.L, 1992 ; Manheim et
al., 1 990) . Thus . s i mp l y reporting the results of t h e s tudy
to hospita l physicians might reduce util ization .
Adminis t rative In t e rvent i ons
Administ rative i n t erv e n t i ons can mea n restrict ions , s u cb as
requiring a second opinion before surgery (Gr e c o and
Eisenberg . 1993) , however the intervention might also be
fac i l i t a t i v e. such as offering i nc r e a sed flexibility f or
di agnostic p r oce d u r es by i nc reas ing the h o ur s that t hey are
ava i l abl e . Administrative interventions must balance the
possible (and generally unsubs tantiated) b ene f i t s wi t h t he
pos sible negat i ve pat ient outcomes an d the in c r e ased burden
on physicians and ot he r s (Gr e co and Ei senberg . 1993).
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Financia l I nc en t i ye s a nd P e nalti es
Due t o e be Can a d ian zee- ror--servi c e sys t em hospitals do n ot
hav e much flex i b ility wi th rega r d t o fin a nci al i nc entives or
pena lties . The r e i s sorne evi dence that ph ysicians a re less
likel y t o hos p i talize their pat i e n ts if they a re paid a
s alary , o r if they a re put at pe rsonal fi nancia l risk fo r
their t reatmen t dec isions (Hi llma n et a L, 1989 ) .
2 .5 CONCLUSI ON S
It can be conc luded that d ata co l lect ion and judgemen ts o f
appropria t enes s of h o sp i tal stay ca n be similarly ma de by
a n y of the met hods dis cus s ed , an d t hat t hey are likely t o be
reliable and v alid . Ongoin g concurrent utilization rev iew
by a t r a i ned nurse p rovides tim e l};' information and r educ e s
t h e expense of pan e l re view . It provides the da ta nec ea s ary
to ide n t i fy p roblem a r eas so t ha t well targe ted i ntervention
prog rams t o improve u t iliz at i on (and a l locative e f ficiency )
can be c reated . Fee dback would p r obably be an effec tive
intervent i on to red uce inappro pria t e ho s pi ta l stay .
Further work using a l arg e r sample i s n e ede d t o measure the
extent and reasons for disagree ment , and t o d e t ermine
whether t he differences in class i ficat i o n of i nappropriat e
days between the AEP and Nu r ses A and B r es ult f rom
differing clas s ifica t ion s yst ems .
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SECTION III
CIPROFLOXACIN UTILIZATION REVIEW
IN THE COMMUNITY
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3 .1 I NTRODUCTI ON
Cip rofloxacin Hydrochl or i de (Cipro) is an expensive
a nt i b i ot ic t hat was released in the U.S . in 1987 and has
rapidly become one of the most f requent ly prescribed o ral
a ntib iotics in that coun try (Frieden and Mangi, 1 990). I t
is a f luorinated qu i nol one ca r boxylic acid d e riva tive wi t h a
wide range of activity a gains t both g ram negative and some
g ra m posit ive aerobic ba cteria . In i nitia l c linical tri al s ,
oral cipro f loxacin was s hown t o be e ffect ive in eradicating
s uscep t ib le bacteria i n t he u r inary t r ac t (UTI), s kin and
soft ti ssue (SST), r espiratory t ract (RTI) , and i n bone an d
join t infections (BJ I) (Grasela et a L, 1991 ) .
Ci profloxac i n of f e rs better a bsorpt i on, wi d e dis t r ib ut ion in
tissues, and a broad spe ctrum of in-vitro act i vi t y against
ente ric gr am -negative ba c ill i compare d to o t her quinolones ,
such as na l i d ix ic acid , norf l ox acin, ofloxacin , a nd enoxaci n
(Lou i e , 199 4 ). It is ba ctericida l by inhi b i ting the
activi ty o f t he ba cterial enzyme DNA gyrase, which is
r equired for DNA r eplicat i on and transcript ion (Hooper,
1988; Shen and Perne t, 1 9 85) . It i s also t he firs t ora l
anti b iotic with e ffective ant i - pseudornona l activ ity (Frieden
and Mangi, 1990) .
Palad ino et a l (1991) compared oral ci profloxacin to
intravenous antibiotics in a cont r olled study o f 105
hospi tali zed ad ult patients who ha d each already rece ive d 8
or more days of i nt r aven ous ant ibiotic treatment for serious
infections . The pa t i en t s continued fo r three more d ays o f
conventiona l intravenous an tibiotics, an d were t hen r andomly
assigned to cont i nue par en t e r a l anti biotics (n _53 ) or switc h
to oral cipr ofloxacin (n",52). Ninety-nine of t he 10 5
patien ts were eva luable for a sse s sment . The c linical and
bacteriologic outcomes and adverse r eact ion frequency with
oral ciprofloxacin were comparable t o those of t he cont inued
i nt r av enous an tibiotic regimens. Ciprofloxacin th us a llows
phys icians to t reat orally several infections that
previous ly r equired pa r enteral therapy. This p r ovi d e s t wo
real advantages : pa t i ents with certain infections no l onger
need to be a dmitted to hospital for parenteral t her a p y , and
i n certain ca s es , pa tient s alr eady recei ving such trterapy i n
hospi t al may be d ischarged earlie r on oral t he r apy (Louie ,
1994 ) . This can t rans late into significant co st savings a nd
free - up hos pital beda .
Grasela et a I (1991 ) studied the effects o f patients
swi tching to ciprofloxacin f rom parentera l ant i biot i c s fo r
Respiratory Tr act Infections (RTI) , Skin and Sof t Tissue
(SST) infections, Bone and Jo int Infections (BJ II, and
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Urinary Tract Infections (UTI) . A t otal of 766 p a t ients
from 54 i nst i t ution s wer e moni tored . It was estimat ed that
~6 , 732 d oses of pa rente r a l ant i biotics were avoided and
t otal drug plus hospital c ost s avin gs of approximatel y
$980, 000 (U. S.) were real i zed . Pa ladino et al (19 9 1) a l s o
found that c i p r oflo xaci n provided sub s t antia l cos t sav i n gs .
with s u ch benefits t o bat h pat i ent and t axpayer ( i n th e case
o f the Canad i an He a l th Ca r e sys tem ), t here i s little wonder
why ciprofloxacin h a s attained its ap p arent ly high
popularity wi t h physicians . In 1989 , cipro f lox ac i n was the
four t h most common l y prescribed an tibacterial prod uct in t he
U . S . (F riede n and Mangi, 1 990) . Ciproflox a c in i s covered by
t h e Governme n t of Ne wfoun d land an d Labr ador' s Soc ial
S ervi ces Dru g Plan a nd t h e Senior Ci tizens Subsidy Drug
Progr am . The number of p r escr i ptions for c i prof l o xadn g re w
quicklY since i t s a ddition to the fo rmulary . now
represent i ng ap proximate l y 10, 000 prescr iptions annuall y at
a cos t of ab o u t $6 00 ,000 per year (Newfoun d l and , De par t ment
o f Hea l t h, 19 94) . Unf ortunately , there is g r owing evi dence
that t h is pop u lar drug i s be i ng i nappropriate pr e scribe d .
Frieden and Mangi ( 19 90) discu ssed fou r case s of
i n appr o p r i at e us e o f ci pr o floxa c i n, but did not address t he
p r evalence of inapp r opria te prescribing . Pickering at a l
39
(1994 ) conducted chart r e views on p a t ients in a l ong-te rm
ca r e s e tt i n g and us ed c r iter i a to a s s ess a ppr op riateness of
presc r ip t ion. Th ey fo u n d t ha t onl y 25t o f p'ree c z-Lpt.Lo ri s
were ap pr opri at e . Rovers and Bjornson (1994 ) applied
pUbli s hed drug use eva l uation criteri a to the Iowa Medicaid
database and fou n d th at on ly 43.at of ciprofloxacin
c ommunity pres cr i p t i ons met the cri teria for
a ppropr i atenes s . Howeve r, onl y 26\ of pat i ent s i den t if i ed
a s rece iving clp r ofloxa cin were included i n the rating of
a pprop r iateness , and t here appe ar s to be subs tan tial bias
wi th respect t o the pr o portion of nu r sing home pat i en ts
i ncluded in the resul t s.
There is, then, some evidence t hat cdp rc ': loxac i n i s being
inapp ropriately u s ed , a lthoug h th ere has b een no
co mprehensive s tudy performed in the community s e t t i ng . The
e ff ect of such mi s -pr escri bing has c ons eque nce s b eyon d t he
c os t i s sue . I nappropriate pr e scrib i ng of ciprof l oxac in can
l ead t o an i ncrease i n c i pro fl oxa cin -res i s tant strai n s of
e nt e r i c gram -ne gat ive b acill i (Louie , 1994 ) . J us t thr ee
months af te r ciprofloxa c in be came availabl e i n the Un i t ed
States , t he fi r st positive cu l t ure f or c i p ro floxacin
r es i s t ant methi c i llin- res is tan t S. a u re us (MRSA ) was
i solated i n a New York City health c a re facility. The l eve l
of c i profloxacin- r e s i stant MRSA sky rocke t e d f rom ot to 79t
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wi t h in one ye ar of i t s i ntroduction in one particular
hospital (Blumberg et al , 1 9 91) . Even more d isturbing i s
evidence t hat t his ciprofloxacin -resistant s train can sp read
from pa t i ent t o patient (Pickering et a L, 1994). Trucksis
et al (1991) found that two thirds of patients infec ted with
f l uoroquinolone -resistant S . Aure us had never use d a
f luoroqui nolone before . Th e s e reports indicate that it will
become i ncreas i ng ly d if f i cul t to t r ea t patients with ser ious
staphylococca l infections in the future (Pickering et al,
1994 ) .
Given t he conce rns of inappropriate prescribing of
c iproflo xacin, t he fact t hat no s tudy has co mprehensively
assessed appropriateness of ciprofloxaci r, utilization i n t he
co mmunity, and that there are no data available fo r
c iproflo x a ci n p r escribing amongs t Canadian physicians , t his
study was unde r taken . I t was des igned t o co l lect c l inica l
data on p at i en t s presc ribed cipr o floxa cin by commun i ty
doctors i n Newfound land, a n d to assess appropriateness of
prescrip tion u s i ng an acade mic panel o f experts. To
identify areas of controversy in the p rescription of
c i p rofloxacin, a panel represent ing the manufacture r of
cip rofloxacin assessed t he same prescr ipti on s . and their
op i n i ons were c ompare d t o t h ose o f the academic pa nel.
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Befor e d i scussing this study ' s methodology, it is u seful to
revie w s ome g en eral concepts of Drug Utili zat ion Review.
3.1 OVERVIEW OF DRUG UTIL:IZATION REV:IEW
Appr op r iate use of drugs i.n th e commu n ity has been o f
concern for decades, and this c oncern ha s i n c r eased as
medications have proliferated , Measurement of app r opria t e
drug use may b e acc o mpli s h e d t h rough a drug ut i lizati on
rev iew (OUR) .
The DUR i n i t s many f orms has exis ted f or over twe n ty ye a rs,
Through th e ~970s , it t encted t o fo cus on drug inte r actio ns
and ove ruse of cont ro lled subs tances , In r ecent years,
however, OUR has ex p an ded to i n c lude n ot on l y such f actors
as exces sive do se , redundanc ie s, and drug~induced diseases ,
bu t at s o cost and the ability t o measu re the OUR's i mpact on
u se and morbi.dity v e rses historic con t rols (Jones, 1991 ) .
DOR can be pc ptnat a cn-baaed , s t u dying t rends in the
a g g re ga t e communit y , or c l i.nical ly~based , s t u dyi ng a sample
o f subjects and mak ing gene r ali z ations to t h e broa de r
community . Up unt i l r ecently, r e l ativ e l y little a t t ent i o n
has bee n giv e n to micro-level DUR in Ca nada (Melnychulc et
a l, 1993). In the last few yea r s, howeve r, increasing
s c ruti n y has b een pla ced on ris i ng costs i n t he pUbl i cl y
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f und ed heal th care sy st em, especially in t h e prese nc e o f
s hrink i n g bu d get s . A sharp i nc r e ase i n drug cos t s t o
provi ncia l formula r i es ha s focu sed a t tention on t h e
appro priat e u s e of d rugs , and has thus incr e ased OUR
a ct i vi t y .
3 .1 . 1 Def in i tion of: DOlt
Various authors have put for t h definiti ons o f wha t OUR
e ncompa s ses. In g e ner al , DURseeks t o measur e an d improve
qual i ty cont r ol and qual i t y assurance of pharmaceutica ls ,
and ca n be a n i nt egral co mponen t of a cos t contain ment
s t ra t egy (Erw in , ~9 9 1 ) . Novi t ch 1199 1 ), asser ts t h at t he
goal o f every DUR b e fi rs t and f o remo s t i mp r oved p a t i en t
I n t h e majo rity o f circum stance s , i ncreas i n g quality
of car e will, i n f a ct , be t he pri mary mot i v a tion f o r doi ng
OUR. Ho weve r , cos t cont r ol in it.self can b e a l egit imat e
r ea son f or carry ing out OUR. Ind eed , one may ar gue t ha t
s aving money on i n a pprop r i ate drug use i n a publicly f und ed
h ea l t h c ar e s ys t em would u ltimate ly preserve fund i ng i n
other areas whi ch mig ht d i r ect l y impac t on quali t.y of care,
such a s diag n ost ic t echno l ogi es , or money t o retain
s pecia l. i s ts wi t hi n th e sy s t em. Knap p (1991 ) defi n e s OUR au
" 8 flex ible and broad ly a p plicable process us ed t o assess
t he qu a lit y a nd e c o nomy of drug pres c ribing , dru g u se by
p atient s , a n d dru g dispensing by pha rmacis ts . - Th i s
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definitio n is pu r pos e ly br oad , since DUR can be carried out
for various hea l th and cost related goals . Th i s section of
the thesis speci f ica l ly reviews the "qu a lity and economy" of
prescrib ing of ciprofloxacin by Newfo und land physicians .
3 .1.2 Retrospective ve rse s Prospective nUR
DUR c a n be app r o a che d retrospective ly or prospectively .
prospective DUR typically occurs at t he time of prescription
or d ispensing of a d ru g . A compu ter sc reen provides patient
hi s t o ri es regarding prescription medicine , 50 drug therapy
problems can be detec t ed be f o re prescriptions a re dispensed
(Er wi n , 1991) . They can be based solely on the professional
j udgements of pharmacists (or physicians) , or c an be aided
by computer -assisted a lert.s (Lipton and Bird , 1 991 ) . The
advantage is an immediate i mpact on indiv i dual patient care.
Historically t he n , prospective DUR pu t s the onus on the
ph arm acis t for patient health . This is attractive in that
it more active::ly i nvolves professionals special ly trained i n
pharmaceut ica ls in t he care o f the pa t i en t . There a r e,
however, severa l disadvantages to r e lyi n g solely on this
approach . First, such a sys t em by itse lf wou l d like ly only
f lag obv ious med ication pr oblems such as ove rdosag e , d ru g
i n t eract i o ns, and alle r gies. It has no a bility by i tself to
i den t ify whether a ce rtain d rug i s being app ropriately
prescribed . Th e pha rma cis t ha s no c l inical data with which
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to de termi n e appropriateness o f us e , and would be una ble t o
quanti tativel}" anal yze agg regate t rends with respect t o ,1
s~c:i f ic drug 'S utiliza t ion . Furthermore . even for t hos e
a reas where t he pharmac ist can inte rvene. t here may be a
lack of the private space an d the time necessary t o conduc t
proper patient counselling (Li pt on an d Bird, 1 9 911 .
Soumerai and Li p ton 11 9951 r e c ent l y r ai s ed a numbe r of
concerns regarding co mputer-based drug utili za t i on r e v i ew,
inclUding questionable va lidity wi t h r e s pect to s c r een ing
criteria, the inabili ty to detect the under -us e of cert a i n
drugs (s u c h a s an t i -hypertensive ag en t s) , and t he
poss i b i li t y o f a dvers e health ou t comes f r om den ying
p r e scribe d d ru g s . Fi na lly. t here a re qu estions a s t o t he
t echnolog ical integrat ion of pha rma c i e s and physicia ns . and
rela ted questions ot confid e nt iality to c onsider . By
i t s e lf, p rospec t i ve DUR is unable t o identify inappropriac.e
prescr i b ing behaviour i n the great e r comnuni ty . an d may
result i n ad ve rse outcomes for i ndividua l pat ients . I n
addition . one of t he key aims of DUR 10 to focu s physicians
on t he i r prescribing be hav iou r so t hat t h ey exercise
prudence when i ssuing prescript i o ns. This goa l co u l d be
seriously undermined when focusing a t t he d i spens ing point.
Retrospective DUR i s a systemat ic proce s s that c ap t u r e s ,
r ev iews . analyz e s . a nd interpre t s da ta o n agg r e ga t e
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medicat ion use within a specific health care environment
(Erwin , 1991) . The data i s a rchival in na t u re , an d is
usua l ly focused on pre s cript i on drugs . However, over-the-
co un ter r emed ies may al s o be t he focus o f DUR, or may be a
va r i ab l e measured in the DUR o f a p rescription medicat ion .
Ret rospective DUR compares drug us e a ga inst predetermined
c r i t e ria t o identify abe r rant patterns or trends, and
provide rs are usually not if ied of the resu lts through
wri tten co nununicat ion . Some analysts cr it i c i ze
ret rospec t ive DUR because i t does not bring abou t an
immediate impa ct on pa t i e nt heal th, so even whe n
i nappro priate prescribing behaviour i s de t e rmi ne d, i t i s
often t oo l a t e to benefit the pa tient (Li p t on a nd Bi rd ,
1991 ). Howe ver , ret rospect ive drug utilizat ion r eview
provides a re lat ively inexpensive way to assess
ap p ropria teness o f use o f a drug , a nd can be us ed t o
i de ntify p rob lem areas where well-targeted i n t e r ven t i on s may
be imp lemented.
In prac tice, one mi ght cons ide r us i ng prospect ive DUR as an
ex t ension of r etr ospe c tive DUR . That i s , retrospective DUR
cou l d be us e d t o i dent ify and measure the ex tent of a
pe rceived probl em, and p r o sp ec t i ve DUR could be used t o
proactively deal wi th the problem. Retrospective DUR
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con t i nua lly f ocus es phys icians on t he i r p rescrib ing ,
inc r easing awareness o f their behaviours. Wh en
inap propriate behaviours ar e found, it might be possible to
program checks and balances into ph armacy computers to
proac tively address the pr oblem. I n a sense, p rospective
OUR can be an i nte rvention strategy necessitated by a
retrospective study, an d made possible by the technology of
int egra ted pharmacy compute r s ys t ems .
3 . 1 . 3 Pr oc e s s of DUR
Er win (1991) suggests a number of s teps in the process of
drug utilization r ev i e w. Included i n these steps are
preliminary dat a ga thering , establishing resource
r e qu i r eme nt s, designing the basic structure of the study ,
set t ing criteria, and data collection and analys i s .
Bra t er ec al (199 1) suggest the data collection process iu a
OUR should p rovide the fo llowing information:
il Patien t Cha racteristics :
Age, sex and b i r t h d"'te
weight and height
Dru g alle r g i e s
Specific c linical s igns and symptoms and d i ag nos i s
fo r t he p rescription of the drug
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i i) Drug Dat a:
Chemical ent ity
Dose ~ strength and frequency
All other medications patient known ..to be taking
Longitudinal history of drug intake
Appropr iate indications f or the drug
Inappropriate indications for the drug
iii ) Hea l th Ca re Utiliza tion :
Pat ient hospitalizations/nursing home use
Office visits
Emergency Room Visits
While there is likely no one database in ex istence whi ch
i n c l ude s all the above da ta , combining several sources can
result in the ac cumulation of a great de a l o f clinical data
on the pat ient . The p ro cess of cha r t review and inte r vie w
employed i n this study captured virtually all of t he data
suggested above . The questionnaire administered by the
interviewer is provided i n appendix C. Beyond these steps ,
one mus t consider i ntervention strategies f or any identif ied
prob lem . Severa l possible in t e r vention strategies will be
ad dressed i n the d iscussion sect ion. Le t us turn n ow to t he
methodology employed in t his study , an d su bsequen t data
a na lysis.
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3.2 METHODS
3 .2 . 1 Sub jec t Selection
The Department of Figure 3 . 1:SUIIlIIlary o f Phys i cians and
Pa t i ents I nclude d in t he Study
Health (DOH)
flagged all
ciprofloxacin
prescriptions
claimed to its
d ru g plans in the
St. J ohn 's region
between December
1993 and February
1 994, generating a
list o f 559
prescriptions by
124 physicians for
437 patients.
Figure 3 . 1
summarizes t he
CO' s. Ca ..u d ty o tficer<<; CP " Gen e r a l
Pra c ti t i o ner
· Cen so r ed" r e f ere t.o ph Yll ici an .. who d i d no t
d ecl1 ne b ut who coul d not be i nt 'l rvlewed bt.-rore
thell tu d y e nde d.
ph ysicians a nd
patients included
and excluded from s t udy . Thirteen resident ( t r ainee)
physicians were excluded because the antibiotic was
prescribed in a hospita l setting, and because they may no t
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have made the decision on drug choice. Four emergency r oom
(ER) casua lty officers (CO' sl were exc luded as i t was
questiona ble whe ther ER physicians were indicat ive of
conununity phys icians . The primar y care phys ician who served
on the ac ademic review pa ne l was a l so excluded i n order t o
avoid p ot e n t i al b i as . Two phys i cians were l os t who had left
t h e province , and t wo physicians co uld n ot be i nc l ud ed
because there was no record of the single pa tient on t he ir
r e spe c tiv e lists. Th irty· t hree (33) patients we r e lost
during t he interview process , mos tly due to t he phys i c i an
e i t her having no r e co r d of the pa t i ent or no r e cord of the
part icular vi s i t . The r e were a lso t wo charts unavailable a s
they were in us e as evidence i n a court case .
Phys i cians we r e interviewed by one of two people: a r e s ea r c h
nu rse an d a research a s s i stant wi th pat i en t c harts pre s en t .
The interviewers used a que stionnaire designed t o extract
patient d emog raphic d a t a , medi cal history, clinical signs
and symptoms of i nf ection , and diagnosis (See Appendix C) .
Physicians were a s ke d what thei r t reatment choice would be
if c i p r ofl oxacin was u na vailab l e for us e . If the cho ice was
to co ntinue treatment on an outp a t ient basis, t he
a l ternative dru g choice was r e co r de d . on ly seven of the 278
quest i on na ires we r e co mpleted sole ly from cha r t review.
Phy s ician and / or i n s titu t i onal consent was ob tained prior to
so
chart review . In total , 72 of 102 (70.5\) ava i lable
physicians were s tudied . Th r ough interview of these
doctors, 263 of 372 (70.7\ ) available patients were studied .
A second questionnaire was completed for eight patients who
had an addi tional prescription from the same physician for a
second separate infections (not re -fills). An addit ional
questionnaire wa s a lso completed for 7 patients who visited
and r eceived prescriptions from two different physicians .
Thus 278 questionnaires were comple ted for review. since
these additional quest ionnaires represent prescriptions for
separate infections or separate and independent physic ian
decisions, they were r e v i ewed by t h e panels an d included in
the analysis. Physicians were compensated at the
Newfoundland partial assessment rate of $15 per patient for
each chart reviewed .
The decision to study almost 30 0 cases was not based on a
sample s ize est imation. Instead, all prescriptions during a
set period were i de nt i f i e d for study . A post-hoc estimatio n
of the sample size was performed, expecting a n approx imate
ap p ropriateness l e ve l of 40 \ . This was estimated using
r e s u l t s from other studies (Rovers and Bjornson, 1994;
Pickering et at , 1994), taking into consideration diffe ring
met hods of data co llection and analysis. A 95\ confidence
interval between 30 \: and 50\ appropriate was de sired .
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Ninety-two (92 ) questionnaires were required using these
conditions. The f inal sample size o f 278 ques tionnaires thus
provided enough data to be confident about the p roportion of
inappropriate cases overall, an d allowed for ana lysis of
appropriateness according to anrect t on - r yp e .
While a solid proportion of physic ians participated i n the
study, one might question whether the physicians declining
to participate represent a possible source o f bias. One way
to compa re the physicians who declined to participate to
those who did is on the basis of the numbe r of prescript ions
per physician. The participants prescribed ciprofloxacin an
average of 4 .23 times during the 3 month periOd , whereas the
non -partic i pants prescribed c iprafloxacin an average of 4 .3 5
t imes ove r the same period . The d ifference was not
significant {t; .. O. Ol 7 , p_O.987). I n addition, the median
number of prescriptions f or both g roups was 2 prescriptions
over t he 3 month pe r iod . It i s thus unlikely that the re i s
any significant bias be tween the prescribing prac tices of
those phys i c i a ns who participated a nd those who d id not .
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3 .2 .2 Patient Characteristics
Table 3 .1 pr ovides
ba s eline
c ha racteri s tic s of
t h e 263 pa t i e nts
to r which the 2 7 8
qu es tionnai res were
comp l eted . There
was a sub sta nt ia l
amount o f co-morbid
illne s s in t his
group , wi th an
av e r age of 2 .8
comorbidit i es and
3 . 6 conc omi tan t
med i ca t i ons pe r
patient . rven ev -
t our percen t (24\)
had he a rt disease.
32' had COPD. and
Table 3 .1 : Se l ected Baseline
Characteri s t i c s f or all 26 3 pa tients
St ud ied .
Pat i ent Baseline Charac t eris tics
(N_2 6 31
_g.
Ra nge 16 -103
Me an 62 .8
s~ I F/ H) 161 / 10 2 (G1\1
Res i d enc e
At Home 19. P4t >
Nur s ing Home 65 {2 St }
Other • ( 2\ )
Current smoker 92 (lS\)
Avg Co· morb idities 2 .8
He a rt Di seas e 63 124tl
Diabetes 34 1l3\)
COPD 8. Il2\)
Allergies
Penic illin 6 1 123\ )
Sulfonamide s 17 P\}
TMP/ SMZ 7 ( 3\ )
13\ h ad diabe tes . Sixty-five patient s (25\) r esided in a
nu r sing h ome .
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3 .2 .3 Ethics
This study was approved by the Human Investigations
Committee, Memoria l university o f Newfoundland . Patient
consent was not required, as no procedure wa s performed on
patients. All pat ient informat ion was kept confidential,
with nu merical i dentifiers f or both the patients a nd
physicians tha t were known only to the investigators.
Physicians were the focus of this study , and initial contact
was made by the DOH. I nvestigators on ly contacted
physicians after the DOH provided a list of ph ys i c i a ns who
did not de cline to be contacted.
3 •2 •4 Panel Review
Two panels a s s es s ed the 278 questionna i res : an ac ademic
panel and an indus t ry panel. The academic panel consisted of
a n infectious disease e xpert, a professor of p harmacy, and a
general practitione r from the communi ty . To h i g hligh t areas
of ag reement an d d isagreement on appropriateness o f
ciprof loxacin use between academics an d i nd ustr y , an
industry pane l also assessed the ca ses . This pan el
consisted o f a physician who i s a r a s earcn f e llow in
c linical pharmacology and epide mio logy ; a product
d ev e l opmen t manage r in anti-infectives f rom Bayer, the
manufacturer o f c iprof loxacin; an d a group health care
5 4
manager i n ant i-infectives from Bayer.
The academic pane l used guidelines from the Committee on
Antimicrobial Agents, Canadian Infectious Disease Society
(1994). Decis ions were made by panel consensus, using the
guidelines and clinical judgement . The academic pa nel was
guided by the premise that efficacious, less expensive
alternat ives should be used where available . Where there is
suspicion of gram positive o r anaerobic organisms
ciprofloxacin should not be used, or should be used with
additional coverage. Appendix D summarizes the academic
panel's guidelines ~or appropriate use of ciprofloxacin .
Once the academic panel had completed its evaluation, the
industry panel, blind to decisions made by the academic
panel , assessed the same cases. The industry pane l made its
decisions using the academic panel's guidelines and
incorporated the Anti-infective Guidelines for community-
acquired Infections published by the Ontario Anti-infective
Review Panel (1994 ), and the Recommendations on the
Management of Chronic Bronchitis from the proceedings from
the Canadian aronchf t i s Symposium (1994).
Both panels first dec i d ed whether the choice of
ciprofloxacin was appropriate for the particular infection,
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a nd if so a s se s s ed t he ap prop r i a tene s s of the dcs. e and
duration o f the pr e script i on . Class i ficat ion of the
rationa le for i n appr opriate prescription was developed post -
hoc , wor k i ng with a pane l member and using t he recor de d
comments of t he pa nel membe rs f rom panel mee t ings (See table
3 .2 for the ac ad emi c panel's r ationa le).
Table 3.2 1 Classification ot Academic Panel Decisions on
Inappropriate tree of CiproUoxacin
1. Not Appropriate for 1st-line Treatment of Respiratory
Tract Infections : Acu te bronchit is , acu te exacerbation or
ch ronic b ronchi tis and communi ty-acquired pneumonia.
2 . Appr opria t e I n di ca tion/Cheape r Al t ernatives : Fi r s t-line
use for lower urinary tract infect i ons and nurs ing home -
acquired pn eumonia .
3 . Inadequate Coverage : Infections where gram + and /or
anaerobic o rg a nisms are suspected . e. g. Cellulitis ,
abscesses , wound inf e c tions and aspiration pneumonia .
4 . Wrong Indication and Cheaper Alternatives : Cases where
t here are f ew dat a to support ciprof loxacin use a nd where
cheaper al t e rna t i ve s ex ist . e .g . o ti tis an d s i nusitis .
5 . Previous Quinolone Failure : Pri or fai lure o f a quinolone
f or the inf ect i on, or use of ciprofloxacin just prior to
the current infection.
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3 .4 STATISTI CS
Yate s - c or r e c t ed ch i -square a nd Fisher's exact test were us ed
to compare t wo categorical variables. The ka ppa statistic
was us ed to assess academic and industry panel agreement,
3. 5 RESULTS
3 .5 . ~ Appropriate n e s s of Presc ription
Overall, ciprofloxacin was considered to be appropriate ly
prescribed in 42. 1\ of the 278 cases (95 \ CI . 0 . 3 6 to 0 .48)
by the a cademic pa nel and in 62 .2 \ (9 5\ cr = 0 .57 to 0.68 l
by the industry panel (see table 3 . 3 ) .
Table 3. 3 : Appropriateness of Ciprofloxacin Prescription for
each pane l , Overall an d by s i te of infe ction .
Si te o f % o f a ll Ac a demic I ndustry
Infe c t i on Cases Panel Pane l
All 100\ 42 .n 62 .2 \
S i. ~ :es
RTI
'"
38 .3\ 66 .1\
GUTI
'"
72 . 6 \ 72 . 6 \
SST ," 22 .7\ 34.1\
• RTI . Raspir...tory Tl'aet I nfeetionl GUTI • Geni toudna r y Tr act In [e ct i on l
SST . Sk i n and Soft TiElaue In fe c t i on
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Resp iratory t ract infections (RTI s) ac counted for 66 \ of the
278 prescript i ons reviewed . For cases of RTI , cip r o fl oxa cin
was considered to be appropr iate ly prescribed 38 . 3 \ of t he
time by the acad e mi c panel and 66 . H. of the t i me by t he
industry panel. Pres c r i p tions f or skin and s o ft t iss ue
(S ST ) infections were considered to be appropriately
pre s cribed l eas t often by both pan e l s (Ac a demi c , 22 . 7 \ ;
Industry , 34 .1t) , while ciprof loxacin was a ppr op r i at e l y
prescribed most often for genitouri na ry t r a c t infections
(GUTI) (72. 6\ by both panels) .
Table 3.4 : Academic Panel Rat ionale for the
161 Cas es of Inappropriate Ciprofloxacin
Prescription
Not Appropriate 66 (41t)
~st-Line for RTI
Appropriate Indication, 40 (25\ )
but Cheaper Al ternatives
Inadequate Coverage 36 (22 \)
Wrong Indication" 16 (10 \)
Cheaper Alternatives
Previous Quinolone Failure 3 (2\:)
Table 3 .4 summar i zes the aca-tenuc panel 's reasons for
inappropriate prescript ion of ciprofloxacin. In 41 \ of
prescriptions , it wa s inappropriately prescribed as first -
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line f or RTI. In 25\ of cases ciprofloxacin was pr e s c r i be d
for i nfecc i ons Ch a t re is indicaCed to trea t . bu t cheaper
alternatives c ould ha ve been used . I n a further 22\ o f ca ses
c i p r o f l ox ac in pro vided i na dequ a t e c overage t or the
in f e c t ion. Of t h e 36 cases that were inappropriate d ue t o
inadequate coverage , 20 (55. 6\ ) would hav e be e n appropr ia t e
had t he treatment been augmented wit h a s eco nd agent
provid i ng anaerobic cc vexe ae , su ch a s c l i ndamy c i n o r
met r on i dazole . rne ect Lona requiring added cove rage included
post -opera t i ve woun d inf ec tions, cellulitis s econda r y to
di abetes o r peripheral va scular disease ( PVDj ,
di ve rt iculitis . a nd several ab s ce s s e s .
Tab le 3 . 5 presents t he rat ionale u s e d by the industry pa nel
for inappropriate
ciprofloxacin
prescriptions.
Tab l e 3 .S : Industry Pa ne l Rat iona l e for
Inappropriate Ci pro f l oxac i n prescription
IN_ I DS)
Sixt y - e i g h c
pe rcent ( 6 8 \) of
t he cases
considered
inapp r opr i ate b y
t he i ndus try pane l
were due e o
cheape r
Cheaper Alternatives
I na dequ a t e Coverage ,
Wr ong Drug
I nad equ a t e Cover age ,
Nee ds 2n d Agent
No In dica t ion fo r U se
Recent Ciprof loxa cin
f ailur e
"
71 (68tl
1 5 { 141j
14 {UtI
" e4\ )
alternatives being available , and 27% were due to inadequate
coverage . The industry panel indicated t hat 48 \ of the
i nadequa te coverage cases were due to need of a second
agent. Infec tions cited as needing additional coverage
included cellulitis (3), wound infections (2),
diverticulit is (2), aspirat ion pneumonia (1) , and a number
of other so rt; tissue infect ions with a high suspicion of
anaerobic organisms . The industry pane l considered
prescriptions o f ciprofloxacin for diabetic cellulitis
appropriate using the Ontario Anti-infective Review Pane l
(1994 ) guidelines , which indicates that ciprofloxacin is
appropriate first -line (pl us or minus clindamycin) for cases
of cellulitis complicated by diabetes.
Table 3.6 provides appropriateness data by physician
diagnosis. Acute exacerbation of chronic bronchitis (AECB )
was the most common d iagnosis and prescriptions fo r it were
considered appropriate ill 34.9\ of cases by the academic
panel and in 88.9\ by the industry panel . Pneumonia
comprised 2U of cases and prescriptions were considered
app ropriate i n 40 .7\ of such cases by t he aca demic panel and
in 74 .6\ of cases by the industry panel. Of 5 9 cases of
pne umonia , 31 were acquired in a nur s ing home. The academic
panel considered prescriptions for nur s i n g ho me -acqui re d
pneumonia to be appropriate in 38 7\ of cases, arguing that
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cheap e r alt e rna t i v e s shou ld have been us ed f irs t . The
i nd\;s t ry panel considered 96 . 7\ of s uch prescr i p t i ons
appro p riate on the ba sis of the Canadian I n f ect i ous Di sease
Society' 5 guidelines used by the academic panel .
Table 3 . 6" : Appropriateness of Pre sc ription for Comnon
Di agno ses f o r each Pane l.
Appropriateness of Rx
Di agnos is
" of a ll
Cases (N)
Acad emi c Indu s t ry
AECB
'"
22 5 6(63 ) (3 4 .9\1 (8 8 .9tl
Pneu moni a 2>\ 24 -14
(59 ) (40 . 7\ 1 (74.6\)
Acute Bronchi tis 14\ 1 3 12(38 ) 134 . 2\) ( H .6\)
Cystit i s •• 1 6 14(22 ) (n. 7 \) 163 .6\)
Cellulitis or •• 3 6Absces s ( 2 3) (1 3 .0\1 (2 6. l\)
Pro s tatitis or 70 1 S ae
I Pvelonephritis (19 1 (7 B . 9\! (9 4 . 7\ )
Otitis or S i nusi t.is 60 • 6(17 ) (4 7 . 1 \1 135 . 3\ )
I n patient s with cellul i t is a nd abscesses c ipr ofl oxa cin was
c ons idered to be a p prop r i a t e ly presc r i bed in on l y 13\ o f
s uch c ases by t he a cademic pane l . The indu s try pa ne l wan
h ighe r (26. 1\ ), but st i l l cons idered cipro floxac i n
inappropria te for most pres cripti :m s f or SST i n f ections .
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Pyelonephr it is an d prostatitis were appropriate i ndi c a t io ns
for ciprofloxacin , and were considered so in 78 .9 \ and 94.7\
of c ases by the academi c and industry panels , however these
infections o nly comp rised about 7\ of the t ot al r evi e we d .
A key f act o r differentiating appropr iateness of prescription
was whethe r ctproz rc xacdn was used as a f irst- o r second-
line a g ent . When the drug was used a s a fi rst-line agent ,
ciprofloxac in was considered to be e.p p'rop z-Lat e .Ly prescribed
in 28\ of cases b y t he academic panel . If prior ant i biot ic
therapy was used , appropriateness rate rose t o 68.8 \ (p <
0 .0 0001) , a n d if there was an antibiotic failure,
appropriateness r o s e f ur ther t o 74\ .
Anot her area of d ifference was be tween specialis ts and
genera l pr a c t i tion e r s . The academic pane l found specialists
t o prescribe ciprofloxacin appropri a t e ly 6 0 \ of the time,
compared to 4 0\ fo r gene r al p rac ti t ione rs (p .. 0 .0 35) . This
differe nce was mainly due t o t he ef f ec t o f 3 uro logists in
t he s pecial ist group us ing ciprofloxacin f o r prostatit is .
Ther e were 25 cases whe re the pa t i en t had two or more
antib iotic a llergies , a nd t his appe a rs to h ave influenced
the d ecision on a ppropriateness . Th e aca d emic p an el
cons idered 76 \ pe rcent of prescriptions appropr i a te wh e n
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there we re two or more allergies (p < O. QOll .
Dosing was usually appropriate ( 7 6\) , with the most common
dose 500 mg BID for 1 0 days. When the dose was
i n appr op r i at e it was main ly due to the dose being too low
{75 \ }. The academic pane l did recognize, however, that it
was difficult t o judge the dose without comprehensive renal
f u nct i o n data and patient body mass . The panel noted that
T ID dosing with ciprofloxacin is inappropriate , and t he r e
were 25 such cases (9 .0 \) in the study sample .
3 • 5 .2 Panel Ag reemen t
There was a
s ignificant
di fference in
r a t i ngs of
appropriateness
b etween the two
p anel s for AECB
<>::2 = 36.65, P <
Tabl e 3 . 7 = Academic and Industry Panel
Agreement
Comp aris o n Agr e ement
Overall p' 0 .67
(N .. 278) K"= 0 .36
sxcr . Nursing Home P • 0 .70
Pneumonia (N • 247 ) K • 0 .41
Excluding P.ECB & N.H P • 0 .79
Pneumonia ( N • 184) K = 0 .58
p . pe r c en t .1.greelllent
K . kappa
0.00001) and pneumonia ( X 2 = 12.53 , pe 0 .0 005), The
d i ff e r e n c e in appropriateness of prescription for pneumc n i a
can be attributed to the difference of opinion regarding
p n eumon i a acquired in the nursing home, with the
appropriateness ra tes being 38.7\ and 96 .7\ for t he academic
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and in dus try pan el s r e spe c tively (p e 0 .0001) . Comparisons
for all other diagnoses y ielded no significant dif ference
be t ween the pane l s (0 .478 e P e 1 .00) .
We also tested panel conc u rrence us in g the kappa statist ic
a nd app lying La ndi s and Koch 's (1977) g u idelines for
inter pr e t a t i on . Kapp a va lues for agreement b e t we e n th e t wo
pane ls are provided in tab le 3.7. Overall agreement was
fa ir (0. 21 c K c 0. 4 0) , but ag reement i mproved to moderate
(0.41 <:: K e 0 .60) when ca s es of nursing home-acqui red
p neumonia were r emov ed . When cases of AECB and nurs i ng
home-acquired p n eumo n i a we r e remo ved a greement remained
mo d erat e , but wa s higher a nd bordered on sub s t ant i a l (0. ';1 e
K <:: 0. 80 ) .
3 .6 DI SCUSSION
3 .6.1 Panel Decisions on Appropriateness
Whe re the two panels agree on inappropriate p rescribing ,
there is litt le doub t t hat the prescriptions were in fact
i n a ppr op r i a t e . Where they di sa gree , one can present
argu men t s for b o t h sides .
Th e panels t ended to agree t hat f irst - line u se for
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commu n ity-acquired pneu monia, acute bronchi t i s , l ower
urinary t ract infections, sinusitis and ot.itis media a re
i napp ropri ate. They also tended to ag ree that ciprofloxacin
provides i nadequate cove rage for most abscesses, post -
operat ive wound infections , aspirat ion pneumonia and other
infec tions where ther e i s a strong possibility of gram
pos i tive and/or a naerobic organisms (Hooper and Wool f son,
199 1) •
There are two clear dif ferences of o pinion r egar d i ng
appropriateness for nursing home-acquired pneumonia and
acute exacerbation of c hronic bro nchitis (AECBI. The
Canad i an Bronchit is Symposium Recommendations on the
Management o f Chronic Bronchitis (Proceedings from the
Canadian Bronchit is symposium, 1994 ) separates patients with
Chronic Obstructive Pul monary Disease (COPO) into seve r-a l
severity groups dependi ng on l u ng f u nction, age, number. of
exacerbatio ns, and number of sympt oms pr e s e n t . Those
r ecommenda tions c ite several antibio tics, i nclUding
quino lones, t hat could b e used empirically as f i rst l i n e
agents if p a tient s fa ll into severi t y categories designated
as " g ro up 3 " or "group 4" , Gr oup 3 pat i e n t s would have one
of t he fo l lowing a ttributes: 11 age over 6 5; (2 ) FEV, <
SOl o f pre d icted l e vel; or (3 ) four or more ecuc.e
exacerbat ions pe r year . Grou p 4 patients h a ve reasona ble
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lung ze ae rve , but h ave o ther r i sk f a ct or s that incr ea s e t he
likelihood o f a poor ou t c ome f r om an acu t e ex acerbat i o n ,
i nclud i ng aqe , poor lung function , and ccmo r bi d illness such
as co ngest ive hear t fa i lure , chronic r ena l failure, o r
c h r on i c liv e r di s e a s e . The argument is that first ·line us e
o f secon d-l ine agent s is j ust.i fied if such t r eatment i s
e xpected to p revent a ho s pi t a l admiss ion , a second course of
t.h er-a p y or f u r t he r d iagnostic tests. The i n d us t ry panel
c ons i dered c iprofloxacin t o be appropriate for AECB pat i ents
who c a n be c lassified as "gr ou p 3" o r "group 4" pat i e n t s ,
s ince the gu idelines provided an ind ication f or quin o lones .
However, s i nce co - t r i moxa zole was a lso included i n the list
of acceptable fi r s t -line agents , it could be us e d fir s t
whe re avai lable as an a l ternative.
The di f f er en c e betwe e n the two pane ls re ga rding n u rsing
h ome - a cquired pneumonia was mainly a cost issue . The
i ndu s try pan el co ns ider e d all but on e case of nu rsing h ome-
a cq uired pneumonia a pp r opr i ate , t he i nappropriate one being
a s pi ra t ion p n eumonia . Of t he 19 ca ses of nurs ing home -
a cqui r e d pneumonia cons i de red i nappropriate by the acade mic
pane l , 19\ were du e to the av a ilabi l i ty o f c heaper
a lte r n.atives. Of t he fo u r rema i ni ng inappropriate cases ,
t h r ee wer e cover ag e issu es (2 aspiration pneumoni a and 1
st rept ococcal pneumonia) , and one wa s due to ciprofloxacin
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use just prior to t he infection .
An othe r area of disagreement between the two pane ls r ela ted
t o 4 cas es of diabetic ce l lulitis that the i ndus t ry panel
consider ed appropri a t e based on the Ontario Ant i ·rnf ect i v e
Review Panel g uide l ines ( 1.994 ) which indica te ciprofloxacin
may be used fi r s t line fo r di ab et i c f o ot ulcer , p lus or
minus c lindamydn . The gu idelines do recommend, however,
t h a t me t ro nidazole o r clindamyci n be used conco mitantly if
anaerobes ar e an issue . T he academi c pane l considered a l l 4
c a s es inappro p riat e . due t o the suspicion o f anaerob es and
need f or add itional coverage, such as c lind a myci n or
me t ron i da zole .
3 .6 .2 Rationa le fo r Inapprop r i ate Phy s i c ian Prescr ibing
P r imary ca re p hysicia ns have fe\<; pr ac tical diagno s t i c aids
to rat ionalize the rapy du ring t h e in i tial consultation . It
usually tak es several days for b acte r iologica l
inves tig at i on , whi c h is o f limi ted benefit , e xcept for
r e t r ospect i ve analys is o f the t reatment (Grab, 1992) .
Cultur es were se nt i n onl y 24 cases ( 8 . 6\ ) i n this study.
T r eat ment is t he re fo r e usually e mpiric, based on l ike ly
patho gens and the s everity of the di s e as e s tate (Grab,
1 9 92) . Joe l Lexch i n (1993 ) po i n t s to the l arge inf l uence ot
d e t ailing by ph arma c eu t i ca l fi rms on p hys i cia n prescribing
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behaviour , stating that 85\ to 9 5\ of Canad ian ph ysicia ns
see pharmaceu tica l detai l e rs, a nd that Bri t ish an d Canadian
g enera l pra ctitioners ranked de tailers as e i ther their first
o r second mos t f re qu ently u sed information s ource (Lexc h in ,
1993) . Pharmaceutical fi rms spe n d ove r $220 million on
det a iling (Le x chi n , 1989), so it is lit t le wonder p hysicians
r e l y on t hi s readily avai labl e s ource of informa t ion .
Fur thennore , many p hys ic i ans a t t e nd company - s ponsored CME
c o urses (Lexc h i n, 19 93) . It is i nt er e s t in g t o note that
physicia ns wer e fo u nd t o h a ve a l ow opini on o f these sources
o f i nformatio n, even tho ugh t hey t end to r e l y on them
(Lexchin 1993 ) . Th i s mean s t hat th er e is a need o n the par t
of physicians fo r r e adily available, d i ges tible a n d non -
b i a sed info rmation.
Pre scription decisio ns ar e also i nfluenced by drug
a v a ilabi lit y a nd cos t (He p p l er e t al, 1982; Howe, 1 916). An
appare nt pr ob lem with the cost f a ct or is tha t many
p h ysici ans seem unaware of t he cost o f the drugs t hey
pre scr ibe . Hux and Naylor (1994 ) surveyed 1.072 phys i cia ns
r e ga rding a hypot hetica l case of acute exacerbation of
chronic b ron c h i tis . They asked t he p h ys i cia ns how t hey
would diagnose and trea t t he patient , and p r ovided a list of
s ix ant i biotics from whic h to c hoose t r eat ment . Two of t he
six med i cat ions were expe nsive ( ciprof l oxacin and c ef a c l or l ,
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and fo ur were inexpensive ( co· trimoxazole, amoxici l l in,
eryt hromycin, and a c ho ice o f te t. racyclines J . One group of
physicians vas g iven drug p r ices with t.heir list , t.he other
group vas not p r ovided dru g prices . The group without t he
prices chose an expe n sive ant ibi o t. i c 38\ of the t i me . whi le
the g roup whic h were s hOlffl p r i ce s only c hose t he ex pens ive
antibiotics l S\" of the time {p < 0 .00l) . Hux and Na ylor
highlight the inadequa cy of phys i c i an k n owl ed g e of d ru g
pri c es, c iting a s t udy by S a f avi a nd Hayward (1992) whi c h
fou nd t hat ieae th an 4 0\ of clinicians wer e able t o come
wi t h i n $1 0 U.S. of t h e pr ice of a one mont h suppl y of their
pr efe rred NSAID or H2 -recep tar an tagon i st [Hu x and Naylo r.
199 4 ; Sa favi and Hayward , 1 9 92 1 . So :.l'hile phys icia ns are
i n f l uenc e d by c o s t , t h ei r l a ck o f knowl ed ge r e gard i n g
relat ive p ricing may lead to i nappropri ate pre scribi ng ot
expensive agent.s .
In t hi s s tudy , tve iss ues a rose with r e sp ect t o
ina p propr iate prescribi ng . F i r s t , there was SUbstantia l
inap propr iate p rescribing o n t he bas i s of etiology of
inf ection and t.he expected pharma cokin e tic p ropert i es of t he
se l e ct ed medicat i on . The fac t t hat 13 \" of c i p ro flo x acin
prescriptions were f o r acu t e bro n chi ti s , a p redominant ly
vi r a l infection (Br own , 1989 ; Gwal tn ey , 1985 ; Phai r , 199 1 ) ,
raises concern s abou t the u t i li za t i on o f ant i b iotics in
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general. The use of ci pro f l oxac i n for infec tions r e qui r i n g
anaerobic coverage raises concerns about phy s i ci an knowledge
o f t he e tiol ogy of these i n f ect i o ns and/ or t h e ant i mi cro b i al
spectrum of the antibiotic be ing chosen . The second i ss u e
r e lat es to t he la ck o f consideration given to t he
acqui sition cost of t he chosen drug , Ciprof loxacin co s ts
ap p ro xi ma t ely $5 ,14 per day for a 500mg BID prescription ,
ye t: the re are a number of cheaper first: Mline alternatives,
i n c l udi n g t etracycl ines ($ 0 . 06/ d a y ) , erythromyci n
( $ ~ . OO/d a y ) . amoxici llin ($ 0 . 66/day) . c c- erdmoxaeca.e
1$0 . 34/ d a y}, and cephalexin ($0. 69 per day) .
3.6 . 3 Limitat ions of t he St udy
Wh i le the quest ionna ire col. lected dat a on co ncomitant
medications , a lon gi tudi nal drug h isto ry was not r e c o rd ed .
Re c o rdi n g such informat ion would have made it impossible t o
co n d uct t he i nterview with i n a 1 0 -15 minute p e r i od .
Physici ans exp r essin g r ecent antibiot ic use o r othe r fac tors
whi c h ma y have contributed t o their decision t o prescribe
ci p r ofl o x acin ha d t h e i r comment s recorded .
Physician interviews were conduc t ed s i x months to one year
a f t e r t h e patient visit discussed . Th i s may h ave resul ted
i n some recall error, however it i s difficult to ascert a in
whether this exrcr wo u l d resulted i n r e call bias . R e call.
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bias is a sys t emat i c depa r ture from the trut h result ing from
imperfect recall of an eve n t , and not simply i nacc u r a cies
due t o recall (Coug h lin, 1.9 90 ) , It i s l ikely t hat s o ma
recall error occurred , howe ve r , t h e chart rev iew comb ined
wi th personal interview shou ld have mi tigate d suc h error ,
and th e re i s n o evi d ence o r r eason to s uspe c t that t he time
period b e tween t he ini tia l pa t ient vi s i t and the in t e rvi e w
r e s ul t e d in a b i ased sample .
Seasonality ma y hav e also played a role i n this s tUdy.
Lo wer respiratory infect ions have a hi g her i n ci denc e i n
wint er (Bro wn , 1989 ; Gwa l tney, 1985; Phair, 1.991) , which was
the period for th is s tud y (pecembe r- February ) . In a s tu d y
o f 129 subject s presenting t o St . J ohn' s pha rmacie s wi t h
p r escripcions for c iprofloxacin, Butler (1995) foun d a
l e s s er perc entage of l owe r RTls than in th is study (47\
versus 66\) . This may refl.ect seasonal. dif f e re nces, since
Butler's study was c arried ou t in March . Ano t her
poss ibi lity, however, is t:.hat Bu t l er' s study ca pt u red a
s light improvement in th e appr opriatene s s of p resc ription,
possibly due t o intervie w of 71 St . Joh n 'S area physicians
just prior t o that s tudy . This is s upp crt.ed n ot on l y by the
fact t h a t th e re were relatively f ewer RTIs (g ene r a l l y
inappropriate) and relat ively more GtITI s (wh i ch were
general ly appropriate ) in Butler' s s t u d y , but also because
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only 42\ of presc ript i ons in Butler's s tudy we r e first ~line,
compa re d to 64\ in this study. Since first~line use o f
ciprofloxacin was as s ociat ed wi th a lower leve l of
ap propria teness , it is conceivable t ha t physician
prescribing improved during the course o f t he OUR.
Ano ther po s s i b l e c rit icism may lie in t h e externa l validi t y
of the s tudy, since a ll patients we r e covered by the t wo
government drug plans. In t he stud y o f patients presen ti ng
to pharmacies with ciprofloxacin prescrip tions , howev e r ,
Butler (1995 ) found that in 103 of t he 129 ca s es (80%) of
ciprofloxacin prescription , the patients we r e not covered by
these governmen t drug p lans . More important ly , t he re wa s no
s ignif icant dif fe rence be tween government i nsu r e d patients
a nd t hose without insurance or covered by privately
insurance co mpan i e s with r espe c t t o t he genera l i ndica t i on
for us e (p ..O.BOl.
Another limi t a tion of this s tudy lies i n i ts i nability to
provide an e s tima t e o f the economic impac t of inappropr i a te
c i pr ofl oxa c i n prescription . The retrospective study design
makes it imposs ible to assess what t he true a l t e r na t i ve
a c t i ons and occurrences woul d have bee n if ciprofloxac in was
avoided in i nappr op r i a t e circumstances . The a l t e r na tive
a c tions and therapy cited by physicians a r e hypot hetical and
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open to su bstantial bias. Do physicians cite expensive
alternatives to make the case seem serious, warranting the
use o f the ciprofloxacin? Alternatively, do they cite
inexpensive medications to show that they are cost-
conscious, and that ciprofloxacin was chosen be c a us e of its
perceived superior efficacy? In S\: of inappropriate cases ,
the physician indicated that the patient would be
hospitalized if ciprofloxacin wa s unavailable for use. Some
might argue that the l a r g e incremental cost of
hospi talization over oral ciprofloxacin may provide a cost
advantage in us i ng t he drug. However , the number of avoided
hospitalizations i s unknown , since outcome data was no t
co llected . Some patients may have required hospitalization
despite the ciprofloxacin prescription . 1.lternatively
i napp r opri a t e prescriptions f or serious SST infect ions may
ha ve led to a hospitalization that may have be e n a voided Iwd
a more appropriate ora l antibi otic been chosen . The only
way to truly assess the e conomic benefit (or c o s t ) of
c iprof loxacin is to conduct a pharmacoeconomic study which
co mprehens ively monitors all health care co nsumpt ion b y t he
patient, i nclud i ng visits to other physicians,
hospi talizations, othe r prescribed medications , laboratory
tes ts, etc . (Boatman et at , 1989) . While this can be
re trospectively achieved, a prospect ive trial which measures
cl i nical ou tcome and a lternative costs is preferred. Suc h a
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trial wou l d be of part icular interest f or the cases of AECB
an d nursing home-acqui red pneumonia , as these are areas that
the industry panel feel that c i pr o fl oxac in may provide a net
economic benef i t.
Finally, pa nel concordance was limi ted by a numbe r of
fac tors, including differing clinical backgrounds, implicit
j udg emen t s us i ng guidelines a s opposed to cr i t e r i on- ba s ed
de cision making, and the possibility of b i as on t he part of
the industry pane l . The ag reement was qu ite good
considering these f actors .
Despite these limitations one c an confidently conclude t ha t
ciprofloxacin is being inappropriately prescri bed,
contribut ing to the productive and allocat ive inefficiencies
whi ch increase the ove rall cost of delivering he a lth care in
Newfoundland. If one wishes to i ncrease eff i c i e ncy in the
s ystem, i n t e r v ent ion s trategies mus t be de vised which
provide co rrec tion without subjecting the health care system
to p ure marke t forces. The fo llowing section d ds cueeee,
severa l possible intervent ion strateg ies to deal with the
p r oblem of over-uti lizat ion of drugs .
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3 .6 .4 I n t ervention Strateg i e s
The l i t e r a t ur e sugges ts a number of possible methods of
reducing over utili zat ion a nd inappropriate use of
pharmaceuticals . The e f f ec t i ve nes s of these interventions
depends on the level of des ired reduction in prescriptions.
t h e level of adverse effect on the availability of certai n
medications to patients, and socie ty 's acceptance o f su ch
"side-effects." Se ve ral i nterventions designed to change
ph ysician behaviour a re discussed here , including clinical
practice guide lines, triplicate prescription proqrema , aud
academic detailing . In addition, overall utilization ca n be
r e d uc e d through prescription limits o r copayments.
Clinical Pract ice Guidelines
Clinical practice guidelines are educational in that they
at tempt to inform practitioners about optimal s t r a t eg i e s for
d i ag nosis and management of various conditions. Practice
guidelines have bee n re latively unsuccessfu l at changing
physician behaviour, however, possibly due to difficulty o f
application t o specific cases, distrust of the "experts"
writing t he guide lines, or because they are not wr itten in
a n applie d f ash ion (Greco &: Eisenberg , 1993) . These
guidelines might be more successful in chang ing behaviour if
disseminated through opinion leaders (Gr eco & Eisenberg,
1 9 93) .
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Tripl icate prescript j o n Programs
Tr i p l i cat e prescript ion programs have traditiona l ly been
us e d t o t arget controlled s ubs t ance s such a s na r cot ics or
benzodiazepines (Schwar t z, 1992 ). A list o f medications i s
provided to physicians f or whi ch they must co mp l e t e a three-
copy prescription f orm in order for the pharmacy to fill the
pr e sc ript i on . The physician retains one copy and gives t he
ot he r two to t he patient t o presen t to the pharmacy , which
in turn re tains a copy a nd forwards t he t hird co py t o the
departmen t of heal th or ot her regUlating agency (Sc hwa rt z ,
199 2 ) . Physicians ca n thus be monitored with r espect to
t heir pres c ribing of these medications , This approach
r educes the utilization of t he targeted medications, but
studies have r aised concerns over l e s s efficacious
alterna t ives being substituted to avoid scrutiny (Sc hwa r t z,
1992; weintra ub et al , 1991) , Further, s op h i s t ica t ed
computer programs such as the Is land Health Information
System (I HI S) recently implemented in Prince Edward Island
integrate government agencies, ph arma c i es and physicians
(West , 1994) make the triplicate prescription idea obsol e t e .
Newfoundland cur r e n t l y doe s not have such a system in place ,
bu t the Newfo undland DOH now requires pharmacies to repor t
phy sician identification code s with each prescription claim
in order t o be r e i mbur s ed. Hig h prescribers o f certain
drugs can easily be tracked anyway, e l i mi na t ing the ne ed f or
76
a triplica te pxes c r -ipt Lon pad .
Acade mi c Detailing
Al so known as educational out reach (Soumerai et a I, 1 9891,
academic deta i ling i s a process whe r e by individual
phys icians are ta rgeted f or educat ion on proper use of drugs
and o t her t herapies (Gr e c o & Eisenberg, 1993 ; Fr a z i e r et a j ,
19 91 ) . Th e ef f iciency a nd effectiveness of such an approach
is suggested by the resou rces dedicated to this approach by
t he ph a rma c e utica l industry (Soumerai et a L, 198 9 ) . There
i s also literature supporting t he e ff ect i v ene ss o f this
approach, In a r a ndomi ze d cont ro lled trial, Avorn a nd
Soumerai (1 983) a s s i gned 435 phys icians to one of three
groups : two i nt e r ve n t i on groups an n a control. One of t he
intervention groups met one-an-one wi t h a t r ained pharmacist
on two oc casions and were provide d ed uca t i on a l mater ial
des i gned f or positive re inforcement. The other Lntervenc Lou
group on ly received printed materials . The one c orr -one group
demonstrated a reduction in prescript ions of tile t i\rg e t
drugs o f 14% (p .. 0 .0001) . Importantly, 92\ of physiciann
approached agreed to meet with the academic detailers (Avor n
s soume ra i , 19 B3 ) .
Hux an d Naylo r (19 94 ) noted that physicians were largely
unaware of t he co st d i f f e r en t i al among various the r ape ut i c
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a lternat ives, but t hey did note that physicians
significantly r educe the i r s e lection of expensive drugs wh en
they a r e provided with a pocket price manu al (Hux a nd
Naylor, 1994; Fr a z i e r et a l , 1991 ) . This suggests that a
s i gnif i c ant dif ference i n prescribing practices might be
achieved through academic detailing with price information
(Fr a z i e r et aI, 1991 ; De Santis et a I, 1994 ) . This mig ht
eve n be accomp lished t hrough direct mai l to phys icians,
which wou l d be inexpensive and relat ively easy to monitor .
However , Soumerai et a I (198 9) sugges t that using pri n ted
materials a lone does not s ignif icantly improve prescribing .
Academ ic de tail ing offers several advantages, including a
strong track record for su ccess (Greco s, Eisenberg , 1993 ) ,
t he poss ibility of net cost savings whi le a t the same time
en hancing physician knowledge , and presumably, improved
quality of care (Sou mera i et aI , 1989)
The re are several concerns with academic de tai ling . however .
No studies of t he effectiveness of a cademic de t ailing have
been done outside the academic sett ings an d the re i s some
c onc e r n about the lasting effect of such an i n te r ven tion
(Soume r a i e t ai , 1989) . The l a t t e r point mi ght not be a
great concern i f a ca demi c detail ing wer e an ongoing process,
as opposed to a t Irne -L dmi t ed exercise as in t he stu dy
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environmen t . A fina l co ncern rests with the reach of
academic detail ing . Butler (199 5) found i n an ex i t survey
of pharmacists t ha t cefuroxime, an expe ns i ve br oad spect rum
ce pha l os po r in, was i ncreas ing i n use ~. n t he St . J ohn ' 5 aten .
It is even more expen sive than c i profloxac i n at t he snma
dosage level . One mi ght question , then , whethe r academic
de t a i ling f o r c iprof l oxa cin alone would p r ov i de suffi c i ent
infonnation t o av oid t he use o f othe r exp en sive
a lte r nat i v es. Furthermore , an tibio t i cs a c t ual l y repr e s e nt a
sma ll proport ion of d rugs p r e s c ribe d i n an o f fice p r actice
(Fr azie r et a L, 1991 ), so one would opt i mally l i ke to s ee a
broad s cope f or academi c d e ta iling, or i ns t eact co nsider
mac ro - l eve l intervent i on stra t eg i es whi ch ca n r e a ch a
broader range o f drugs te g. c opayments ) . Howeve r , t he r e is
a great deal of literature s upport i ng academi c detai ling,
and the advantage of inc r eased physici an knowledge cannot be
understated.
Prescript ion I,j mi ts
Prescription l imits represent a se v e re c os t containment
s trategy i n whi ch limits are placed on t he nu mber o r t o ta l
value of prescript ions reimbursed on a monthly basis
(Soume r a i et a L, 199 3) . While the restriction itself may
force phy sicians to prescribe the mos t nec e s s a r y and
appropr iate medications for their pat i ents , it i s no t a
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mea sure which is designe d to reduce inapprop r i a t e
prescribing. I n a s tudy of the impact of a Medicaid
prescript ion limit of 3 prescr ipt ions per month in New
Hampsh ire, Saumerai ec al (199 1) detected a 35% decline in
the us e of study drugs after the cap was appl ied , with no
change in the comparison cohort . However , l i mi t ing
re imbursement for e ffective drugs was found to put frai l,
low-income , e lderly pa tients a t increased r isk of
institutionalization in nursing homes, increasing the cost
to t he Medicaid program (Soume r a i ee aI, 1991).
Prescr iption limi t s , while r educing t he utili zat ion of non -
essential medicat ions, a lso r edu ced the util ization o f
essential medicat ions, s uch as i nsu lin (-28%), t h.i.az i dea (-
28%) , a nd furosemide (-30%) (Soumerai et a I, 1987). While
this approach seemed effective i n l owe r i ng the number of
prescriptions reimbursed , the nega tive heal th ou tcomes and
quest ionable net economic pa yback make thi s approach
undesirable .
~
copayments a re a method of cost sha ring between the insurer
and the pat ient. They can take the form of D. pe r c en t a ge of
the prescription cost (o ften 10 to 15 percent of
p r e s c r i p t i on cost), or a f i xed f ee of one to t h r ee do l l a r s
per prescription (Soumerai et a L, 1993 ). Copayments as l ow
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as f i fty cence U.S . have been fo und to reduce prescriptions
by 20\ (Soumerai ee al 1993; Nelson et aI , 1984 ; s mith ,
1993 ) , a lthough a ccoun t i ng for i nfl a tion , t ha t va lue is
actually just over $ 1 U.S . (Smith , 199 3 ). Medicaid programs
that have i n t r od u ced s uch copayment s have all observed
decl i nes ranging from 5 t o 1 0 pe rcent in overall drug
u tiliza tion , howeve r , there i s a l s o some evidence t ha t even
mode st cos t sharing can r e su l t in the reduct ion of
"esse nt i a l" agents as well as l e s s e s s en t i al agents
(Soume r a i e t aI, 199 3 ) . In addition , s ome econo mi s ts a rgue
that the ef fect iveness o f an y use r cha rge in t he he al th
servi ces market i s inherent l y limi ted by the informat i on
asymmetry between patient an d doctor 18lomqvi st , 1994) .
Despite t he s e shortcomings, the increase in the elderly
population quali fy i ng f or drug program benefits coup l ed with
the prod u c t i on of ne we r, more exp e nsiv e drugs that h av e
ex tended pa tent protection will likely further strain t he
provi nci a l drug plan (Mc I s aa c et aI , 1 994 ) . While s pecific
i nterven t ions aimed at reduc ing i napprop ria t.e physician
p rescribing are preferred , governments may be forced t o
co ns i der mac r o-level i nte r ven t i ons , such as c o- peyme nt s , in
o r d e r t o co unter act these pressure s . Gi ven t he heigh t en ed
socia l and p olit i ca l sensi t ivi t y s urround ing the a pp l i cation
o f su ch a n intervent ion eo ne edy Canadians , provinc ial
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governments should search for innovative variations which
a t tempt to captur e the be nefits of market co r rection ,
wi thout undue hardship. If a generalized co -payment seems
too draconian a measure, than one might wish to consider
select ively applying a copayment to drugs which are
expensive an d over-used, and where eff icacious and cheaper
a lternatives exist. This would provide a lower net benefit
to the program, but would inject some market forces where
they are needed mos t . Ot her op tions exist , such as tighter
administrative control on the government formularies . Th i s
mig ht include de -listing drugs, or requiring written
justif icat ion f or the use of certain agents . Of all the
a lternatives academic detailing appears to have the most
promise of the exist ing alternatives . Of cou rse another
alternative is the status quo . However, that is
unacceptable, s ince the growth in the cost of these drug
plans will divert funds from other health services in a
l:t:!latively fixed aggregate he a lth care budget.
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3.7 CONCLUS I ONS
One can conclude t hat c iprofloxacin is being inappropriate ly
prescribed for a numbe r o f i n f e c tion types, including first-
line for ccrnrmmdey -ecqudred upper and lower r e s pira tory
infect ions and certain skin infections , such as abscesses
and cel lulitis . Inappropriate prescript ions seem to stem
from a combination of l a ck of knowledge o f pha rmacctiher apy
for common infections, as well as a lack of knowledge or
concern regarding the cost differential among antibiot ic
a lternatives . Some differences in opinion ex ist betwee n
academics a nd i ndus t ry regarding the appropriateness o f
ciprofloxacin use for acute exacerbation o f chronic
bronchitis and nursing home -acquired pneumonia.
prospective pnarmeooeccnoms.c study is required to answer
broader questions regarding ciprofloxacin use in these two
areas . Where inappropriate prescribing is due to the
ex is tence of cheaper a lternatives one can conclude that
productive efficiency is being compromised. One might
consider inappropriate prescribing due to infection-type t o
be a form of a llocative inefficiency. Given the high degree
of inappropriate prescribing by phys i c i a ns . educa tion on
proper microbiological and cost-effective use of
c!prof loxacin and other antibiotics is needed. The
literature supports using academic detail ing to ed ucate
physicians and reduce utilization of over-used drugs. There
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a re some i ndi ca tions that other expensive antibiotics are
increasing in use . Given the broad range of pharmaceutica l
t herapeutic choices ava ilab l e, it i s r ea s onab l e to conclude
that mis~prescribing of drugs is not res tri ct e d to
c i p r ofl oxacin or eve n ant ibiotics fo r that mat ter. A broad -
based approach , such as co -payments , may be necessary to
address t h is systemat ic prob lem . A co-payment that f o cu s e s
on ly on problem areas cou ld be useful , but requires stud y.
Since co- payme nt s ar e not poli t ically expedien t, ac ademic
detail ing should be employed to address current over-use of
c iprof loxacin and antibiotics in general.
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SECTION I V
SYNOPS IS
8 5
The delivery of health car e resources i n Ne wfound l and h as
be e n sub-optimal due to allocative and p rod uc ti ve
inefficiencies . Th is t he s i s has e xamined measurement of
a Lj .ocac Lve efficiency in the context of bed ut il izat ion
review. It has demons trated t ha t trained nurses c an
reliably and va lidl y collect da t a on i np atient s t ay a nd
decide whether each hospital d a y i s appropriate using
partial ly su bj e c t i ve techniques . Nurses may also make s uch
judgments using a modif ied form of t he Appropriateness
Evaluat ion Protocol .
The a r e a of greatest disagreement wan fo r classif i cat ion o f
the i n a ppropr i a t e hospita l stay. Hos pi ta l admin i strators
might t hus be somewhat concerned about their abili t y t o
in t e rpr et the da ta , and t hu s t a ke c o r r e c t i v e ac tions when
inappropriate stay ha s b ee n identified. Fu t ur e resear ch
should use a larger sample to measure the extent of a nd
reasons f o r disagreement , and t o determine whe t he r t he
differences in cfaaodr Lcat Ion o f i n a pp ro p r i a te sta y between
t he AEP and Nurses A and B resu l t f r om differing
c lassi fica t ion systems .
I nappropriate uti lization o f ciprofloxacin is but one
example of productive i n efficiency with i n the he a lth c a re
system . Ant ibi otic overuse seems to be e ndemic, thus f u t u re
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re search s hould quant ify t he extent of the problem, as well
a s identify r ea sons for this behav i our . Research should
also be conduc t e d in t he area of a cademic d etailing t o
reduce i napprop r i at e physician pz-eacr Lbdnq a8 one means of
reduc ing t he productive inefficiencies i n t he Newfou ndland
health ca re system.
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APPENDIX A
CONCURRENT BED tlT:ILIZATION RE'VI:EW
Standardized Dat a Collection Form
'0'
Ho spi tal: _
1l(, :; I" '~ II(;t.· :
Tyl't' 0 1 Adllli SSIOII : _
Se rv ice :
Phys ic i an :
n a t e a n d Tim e 01 Ad mi s s i o n :
Reason fo r Adlll s s i on :
Confi r med Di aq nosi s:
Medical Status on Admi s s i on :
1 . Rout ine
2. Urgt>nt.
3 . Ell e rg ency
Ward :
Ro o m:
S oc ia l Hili t ory and Funct i o na l S t a tu s o n Adm i ss i o n:
Li ves Al one:
Ambul a t o ry Sta t us: __
~ : ~~s c oeeen t e r _
1 . In de penden t
:;:. Requ i r es so me Assi s t anc e
3 . Bedb o u nd/B e d -C hai r
Co mments : _
Bowe l
r nccut r oem : are c eer
1. Yes
2. No COlll/lle n t.s:
o r t eu t ec t o :
D illch a r g ed :
t r me
rt e c e
f't'r s on
1 . Yes
2 . No
1 . Yes
2 . 11:0
comment s :
Comments : _
Da t e o f Di s cha rge :
Le ngt h of St a y :
M
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APPEND I X B
Cate gori e s for As sessment and Cl a s s i f ica t ion o f
Inap p r opr i ate Days
AWAITING SURGERY
1 . Premature admission - O.R . date booked, but patient
admi t ted more than 24 hours prior to surgery .
2. Elec tive Surgery - Specific procedure should have been
admi tted thr ough same-day admission clinic.
3. Admitted for surgery; Delay in scheduling
4 . Awaiting Surgery - post-diagnostic procedure > 24
hour-uj patient condition is stable - should be
d ischarged and r'e admf.t t ed .
5. Scheduled for surgery, 'bumped' because of emergency
6 . Delay in surgery due to "40-hour week" problem .
7. Delay because of indecisiveness of pat ient /fam i ly .
8. Delay due to equipment failure.
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Appendix B - Continued
AWA I'1'IHG DIAGNOSTICS
1 . Ad:nit t ed d a y before a diagno s t i c pro cedure t hat s hould
have been a same-day procedure .
2 . Book e d fo r that day, cancelled and r e sc heduled .
) . Orde red, b u t ;I 24 hour s wai t ing for pro ced u r e t o be
done
4 . Delay Due t o ~ 4 0 h our week problem."
S . Dela y due t o in d e c i si ve n e s s of pat i ent/fami l y .
6. Admitted d a y befo r e chemotherapy - Bl ood wo rk s h ould
have been d one t h e day b e fore.
7 . Diagn o st i c p r oced u r e co u ld have been done a s ou t patie nt
pro c edure .
AWAXT ING CONSULTS
1. Ord e r e d bu t not sent .
2 . Avai ting > 24 hou r s for a sse s s ment b y conSUl t i ng
physician .
AWAI TING RES ULTS
1. Results not ava ila b l e (> 2 4 hours )
1 05
Appendix B ~ Conti nued
DI S CHARGE PROCESS
1. Delay i n itiating discharge plan, ie. sending
appropriate consults or contacting Conunu n i t y Hospi tal .
2. Delay in d ischarge home ~ no longer requires inpatient
services in an acute care h o s pi t al for Dx and/or Rx.
3. Delay in dischar ge to hostel or othe r rocai
accanvnodations for remainder of care .
4. Delay t ransfer to Community Hospital - for further
co nvalescence at lowe r leve l care ; long term care {p Lan
ha d bee n initiated ) .
5 . Delay in trans f e r to Long Term Ca re - h a s been
i de n t ifie d as requiring long term care .
6 . Delay i n discha rge because o f ot her as s e s smen t required
outside the institution (en riched need s . Vete rans
Aff airs assessment, etc).
7. Delay in discharge because f amily / pati ent not in
ag reemen t with p l an .
a . Delay in discharge be cause of unhealthy home
environment, a n d unab le to return to same .
9. Discharg e/trans f e r de layed h e caus e phys ician wr o t e
di scharg e orders t oo l a t e i n the day.
10 . Delay in t r ansfe r to Convalescence; identified as
appropriate for ccnve i .
11 . Other
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Append.ix B - Continued
MEDICAL w.NAGEHEN'T
1 . In a dequ a te preadmiss ion assessment , ca us ing delay i n
comp l eting proc edure/ t r eat ment .
2. In e fficient t e st sequence a tter a dmiss i on cau sing d e l ay
i n d i agno s is and/ or t r eat · tt .
3 . Ove r l y conservati ve trea t luent In o thing much done for
three day observat ion) .
4 . Admitted pos t s u rge r y for observation ; could h ave gone
to h os t el , r e t u r ni ng for recheck in a . m.
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App endix B • Continued
REOP':IRING SERV:ICES OTHE R THAN ACQ'rE CARE HQSPJ:TAL -
CURRENTLY NOT AVAILABLE '
CONVALESCE NCE/REHA BIL I TATIO N
1 . Pat ient po s t surg e ry - nee ds addi tional c o nva l e scent
perio d for f requ e nt dressing changes or IV antibiot ics .
2 . Pos t CVA - stable , r equ i ring skilled nursing, Physio-
and Occupat i ona l Therapy i nt e r vent ion .
PALL I ATI VE/SUPP ORTI VE CARE
1. Terminally i ll , only supportive care i s required which
can be gi v e n outside an acute ca re set t ing .
EXPANSION HOME CARE SERVI CES - I V TEAM MEDICAL DAY CARE
1 . Receiv ing I V ant i b io t i cs , usu a lly for lo ng term
treatment , with Hickman Catheter i n place , is med i cal ly
stab le , and lives withi n th e b oundaries o f the Home
Care Pr ogr a m.
2 . Requi res complex dressing cha n ges , bu t with
intervention /supervision of a pr ofessiona l , could be
managed at home - geographica lly wi thin t h e bou n da rie s
of Home Care .
l OB
Appendi x B ~ (ConUn u e d)
ltEAS QNS FOR INAP P ROPR.I A TE ADMI SSION DAY
A. pat.Lent needs no inst i tution a l care > d iagnos i s and
trea t ment. can be hand l e d on an out.patien t bas is.
B. Pat ient needs i ns tit u t i onal c are a t a lowe r l e v e l t h a n
an a cute care hospital - gene ra l (u nspec i f i ed ).
C. Pat i ent needs ca r e in a chronic di s ease h ospital.
D. Pat i ent need s ca r e in a skil l ed nurs i ng home.
E . Pat i e nt ne eds ca r e in a non-skilled nur sing home .
F . Prematur e a d!llis sion (e g . on F riday f or a proce dure
boo k ed for the f o llowing Tuesday) .
G. Pat ient d o e s not need a cute i n s ti tu t i onal car e f or Rx •
r equires fac ilities providing minima l su p e rv i s i o n lie .
min a s s . ADL and supervision ) .
i c
APPENDI X C
Questionnai re used f or the Ciprotloxa cin
Drug Utilization Review
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CIPRQrkOXAC'IH IN !HI cOMMl2Hxn
Pathnt No.__
pb y.lc:ian NOI _
SeXI __ 1 . Kal.
2 . Pe..m.a1t
Buid encylO At B'olll
o Hurting DOIll.
e Ot,hu
CASI pBS CRIPTION!
CLA SSIYZg.TIOH Qr CURRENT I Nl I!CTIOlh
!lYHlli
o MUd
o Hod.rate
o Sever.
INDIgTZONSt W'a. t he !Dfeettolll
e Acute
e Chronic
o Acuta on chr onic
Respiratory
OeD:lto-urlD'ry
Skin/ . oft. ti..u.
Other
aYe.
aYe'
aYe,
aYe,
o H.
o H.
o H.
o H.
Current !neUe . HOD fo r vhlcb 'IPRQ Val p ruer ib, d!
RBSPIRATORY TRACT INFBCTION
ltpp e r Rup lnto ry Illf . c tion .
o S!D\ldti,
n Otit.1l
o Lary2l!litb
o Phuyngitlto Ot her , _
III
Lower Respiut.ol'y InfectJon :
C Acute bronch I ti.
C Acute e.lllcerbaUol\ of chronic bronchiti.
o PneumonJa
o Acute ulcerb.t.lon ot Cy8UC Ubrolll
C Acute eucerb.Uon ot bro nchlec:tui.o Other: _
URI NARY TRACT INFECTI ON
o Cy.t1ti.
o 'rostati.
C Pyelo nephrit.i.
o Orc h i ti., epldld}'J'it1l1 . or epldidym o-
orch i ti .o Other : _
S KIN/SO FT TISSUE/OT HER I NFECTION
o Absc e u
o Celluli tis
o Foot ulctr
o Deeub Hu s ulcer
o Post operative wound infection
o InfectiOUI dhrrhea
o Bone/joint infectiono Other I _
C"[ CnUT OF CLI NI CAL SI GNS AND SYMPTOMS
Respiratory Tract InfectI ons
C Fever
o Rigor.
o ChUl.
e Cough
o Sput~
a Hael'llopt)'l1.
o Dylpnea
a Tachypnea
o Rales/cracklelJ
o RhonchJlwheeze
C 'leur Hie chest paino Othe r 1 _
other infectionl/condition. :
112
Urinary Tract Infection.
o Fever
o R190tl
o Chilli
a Dysuria
a Urgency
o Fr equency
o Flank paln
o Suprapubic patn
o Urologic llbnorllllllltyo Other: _
Does the patient have Jlno'oiT'l antib Iotic alh rqIu1 0 Te. 0 No
COHHEtn'S :
Had t here bee n pr evi ous occ urrenc es of this condition In
the prior 12-24 Ilonth. ? C YII 0 No
It yu, spe cify how many previous occ ur re nces t her e had
been l
Had thl. condition been persistent t or l onger t han a ont week
peri od pri or t o the pr es cribing of CIPR O? C Yu 0 No
If yu, t ota l dura tion of co nd1t lo n:_ _ da y .
CUL1VR! REPORTS:
Wu • culture senU C Yes C No
'%'ype of culture suple lie . sp ut ua, urine) :
Type of Culture s usp ect Viral/Bacterial1.===2 .a,
PO D UL'I'V'RESOE OTE C .
NO. ORCANISIH S ENSITIVI TO RES I STANt TO
I I'
N2n pha tp{cqlogS"11 aetlon ,
o EmergeDcy department
a Rl di ology
o Out pl t ie nt. department
a AW t te d to bo.pit.l
g ~:h:~t~;,,::r:;;d'----
CI PR OrLOXACIN PRI SCRIpTION,
o Confined to bd
o Confined t o bou..
a Not conUned
o DoG't Know
Date CIPRO pr8ll cribed l __
DD Ki4 yy
Intention l Sbortter1!l Rxl__ or Lon g te1"1ll Propbylaxh ,__
ue ee prescribed l
-- ..
Fr eque ncy l Dunt i on l Route l
__ D<ly'
Is t his pre se nt pres cription c on t inu io g treatm ent previously
prescribed by I epecialist? 0 Yet C No
Pro RiIO O....~S.T"" (:2 'ItS a ~b
Previo ua M ti bi oUc Trea tmegt!
Wa. t he pathnt on any previou. antibiotic thenpy for tbh
c u r ren t .pllede? C Yu 0 No
NAXl l (Gen e ric ) ======(Trade)
D08e prescribed l
- -- ..
Fr equ encYI DuratioDt
_ _ Day'
Route!
Did tbh antibio t i c taU to treat tbh c onditioa1
C Yn 0 No
What meae ure(.l would you have taken AND what medi cation would you
have preecdbed if CIP RO had NOT be ea available to t r eat tbh
p atient?
Meae ure taken! o Still tre.t .... an outp.Hent
a Refer patient to • Ipechlht
o Hoapit'1!u paUent
o No d i f fe reD t mouurn
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Wha t. llledlC'aUon! .....ou l d you have pruC'rlbed ..., " 'lIb,titute t or
CI PIl.OI
I. NAME: (Generic)
(Trad ')
Do. ' : Frequency : Durat1 on :
"9
--
Day.
2. NAJ1E . (Generic)
(Trade)
Dose : Fr eq uency : Duration:
"9
- -
DaYll
ACCOHPAKYI NG 011. UNDEIl.LYING
DISEASE/CONDITION
Rout, :
Route l
CONCOMITANT ME ICATIONS:
TRADE NAME GENERIC NAME
,
--,
115
RESWCH NURsE INTERVIEW NOTES ·
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Appen d ix D
Summa ry o f Guide lin es used by the Aca d emi c Panel
DEF I NITE INDICATIONS FOR CI PROFLOXACI N
Mode rate t o Severe I nfections
Have previously required 3 ~d ge ne r at i on cephalospor ins or
a minogly cos i de s and the patient c an be swi tched to oral
medicat i o n . e .g .
• Pneumon i a
• AECB with res is t a nt organ i sms
• A. E . o f bron chie ctasis - known r e s i s t ance
• Uppe r UTI with re s ist a nt G - organisms
• I ntra-abdominal sepsis ( -t anaerobic coverage )
• Non-fungal s upe rin f e c t i on s
Mi l d t o Mode rate Se v e r i t y
• Cyst i c f i brosis a nd bronchiectasis exacerba tions
• COPD not r es po nd i ng t o other an t ibiotics
• Recurrent UTI with r esis t a nt organisms
• Acut e and Chronic Prosta t i t i s
• Sinusitis not responding to less expensive a nt i b i o tic s
• Diabetic foot ulcer if used. with ana e rob i c c ove r ag e
• Tr aveller 's diar rhe a and p r op hylaxis
• Chronic recurrent a nd resis t ant o tit is media
CI PROFLOXACIN HOT INDICATED FOR :
• I n f luen za and o the r respira t ory mani fes tat.io ns
• Acute bronch i t i s , pharyngit i s and laryngitis
• Pe l v i c Inflamma t.ory Disease
• Commun i ty-acqu i r e d pneumonia
• Acut e otitis media or sinusitis
• Skin Abs c e sses
• Mon ot herapy f or aspiration pn eumonia and cellulitis
11 7




